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Healthy skeletal muscle has a robust ability to respond to tissue damage. Restoration of 
functional tissue depends on cellular expansion of muscle stem cells, a.k.a. satellite cells 
(SCs). During resting conditions, healthy muscle fibers have minimal turnover and SCs 
are mitotically quiescent. However SCs exist in a reversible quiescent state.  Tissue 
damage prompts quiescent SCs to enter the cell cycle to produce progenitors that will 
differentiate to form new muscle fibers (myofibers) while a portion will self-renew to 
preserve the stem cell population. The notion that growth factor deprivation during rest is 
responsible for quiescence led to the widely held belief that quiescence is a passive state.  
But more recently, researchers have characterized molecules that maintain quiescence by 
inhibiting proliferation, leading the field to reconsider this notion and recognize 
maintenance of quiescence as an active state. However the mechanism by which SCs 
maintain proliferative potential during dormancy has not been studied. 
 
Here, I have identified a CREB-Mpp7-AMOT axis that directs proliferative competence 
during quiescence. Using a tamoxifen-inducible, Pax7-lineage specific driver to 
inactivate CREB in SCs, I found that CREB inhibition does not cause a break in 
quiescence.  However, upon muscle damage, SCs without CREB activity showed 
defective regeneration, attenuated proliferation, accelerated differentiation, and lack of 
SC self-renewal.  Using RNA-seq based transcriptome comparison and ChIP, I 




overexpression, I found that Mpp7 is necessary and sufficient to maintain proliferation 
and self-renewal.  Additionally, I found that Mpp7, a scaffolding protein, promotes the 
polarized localization of AMOT protein and nuclear accumulation of YAP.  In summary, 
I discovered that CREB regulates Mpp7 expression thereby mediating a Mpp7-AMOT 
protein complex to promote YAP activity upon activation.  Lack of CREB activity does 
not affect quiescence per se, but severely attenuates activation during an injury response.  
My work delineates a novel protein network that maintains SC activation competence 
during quiescence for stem cell function. 
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 Muscle stem cells 
 
Skeletal muscle enables locomotion of vertebrates.  The basic cellular unit of 
skeletal muscle consists of the myofiber containing the actin-myosin contractile unit that 
enables force generation.  Intimately associated with myofibers are SCs, named such 
based on the early observation by electron microscopy of their position sandwiched 
between the basal lamina and cell membrane of the myofibers (Mauro, 1961).  Because 
of their close juxtaposition with the myofiber, SCs were hypothesized to be involved in 
muscle growth and regeneration (Mauro, 1961).  Subsequent experiments using 
radiolabeled thymidine to trace newly synthesized DNA showed that SCs were 
proliferative and contributed to newly formed myofibers (Moss and Leblond, 1970, 1971; 
Reznik, 1969).  Culturing isolated myofibers and associated SCs revealed the ability for 
SCs to migrate away from the myofiber, proliferate, and differentiate fully to form multi-
nucleated myofibers (Bischoff, 1975; Konigsberg et al., 1975). Thirty years later, 
techniques to characterize SCs, such as label retention and transplantation, has been key 
to showing that SC is a bona fide muscle stem cell in vivo (Collins et al., 2005; Shinin et 
al., 2006). 
The functional role of SCs has led to the interest in identifying the molecular 
properties of these cells.  During embryonic myogenesis, a progenitor population arises 
from the central dermamyotome, expresses Pax3 and Pax7, and are maintained 
throughout the developing skeletal muscle (Fan and Tessier-Lavigne, 1994; Gros et al., 
2005; Relaix et al., 2005). These cells will settle in to the SC position during late fetal 
development, mirroring their location in the adult muscle (Relaix et al., 2005).  Using 




embryonic precursors do indeed mature into the adult SC (Hutcheson et al., 2009; Keller 
et al., 2004; Lepper and Fan, 2010).  Previously limited to germline mutants, the advent 
of lineage-specific conditional-activation of Cre by the Cre-loxP system allows for SC 
specific deletion of genes.  This enables the study of gene function of germline lethal 
genes as well as SC specific manipulations using the canonical biomarker Pax7 to drive 
specified gene deletions. 
 
Skeletal muscle regeneration 
A central property of stem cells is the capacity to generate daughter cells that self-
renew and differentiate into specialized cell types (Weissman, 2000). Mammalian stem 
cells of rapidly regenerating tissues such as the hair follicle, intestinal crypt, and blood 
are predominantly quiescent while a subset are actively cycling for ongoing tissue 
restoration (Li and Clevers, 2010). Skeletal muscle, during normal physiology, has low 
turnover and fittingly, resident muscle stem cells rarely become activated. SCs are 
normally quiescent (Schultz et al., 1978), however, upon tissue damage, have robust 
capacity to mount a proliferative program to provide the necessary cellular source for 
generating new myofibers (Brack and Rando, 2012). In response to injury, damaged 
myofibers undergo a degenerative phase in coordination with SC activation to replace 
lost tissue.  Proliferating SCs generate mono-nucleated muscle progenitors, termed 
myoblasts, which undergo fusion to form multi-nucleated myofibers.  Myogenic 
progression of SC derived myoblasts are marked by overlapping but distinct expression 
of muscle lineage specific genes that designate quiescence: Pax7 (Seale et al., 2000); 




al., 1987); differentiation: Myogenin (Mgn) (Wright et al., 1989) and Mrf4 (Rhodes and 
Konieczny, 1989); and terminal differentiation: myosin heavy chain (MHC) (Bader et al., 
1982).  Alterations in the timing and level of expression of these markers indicate an 
abnormal myogenic program. 
In addition to SC derived myogenic lineage, muscle-derived pluripotent stem cells 
have been suggested to contribute to muscle growth.  Bone marrow cells and muscle 
derived, hematopoietic stem cell marker Sca-1+ cells were able to form myocytes and 
SCs after intramuscular transplantation (Asakura et al., 2002; Gussoni et al., 1999; 
LaBarge and Blau, 2002).  Muscle resident PW1+/Pax7- and CD45+ interstitial cells have 
also been shown the contribute to the muscle regeneration in vivo (Mitchell et al., 2010; 
Polesskaya et al., 2003).  Similarly mesoangioblasts and pericytes have the capacity to 
contribute to newly formed myofibers during regeneration (Dellavalle et al., 2007; 
Sambasivan et al., 2011).  Nevertheless, ablation of the SC population results in complete 
absence of muscle regeneration, providing evidence that SCs are the major contributor to 
muscle regeneration under the normal physiological conditions (Lepper et al., 2011; 
Murphy et al., 2011; Sambasivan et al., 2011). 
The ability to reform skeletal muscle after damage is of paramount importance to 
the quality of life.  Traumatic injuries, such as heavy weight lifting, mechanical damage 
and downhill running, engage the SC to proliferate and form new muscle. Disease states 
such as muscular dystrophy, cachexia, and aging, are accompanied by reduced ability to 
regenerate due to SC defects.  Therefore, the understanding of the basic biology of SCs 
can inform translational medicine with the goal of restoring muscle growth and function 






Stem cells are a long-lived population of cells that enable tissue growth 
throughout the lifetime of animals.  SCs have a remarkable capacity to proliferate to form 
the necessary cells for muscle regeneration. Transplantation of a single myofiber an its 
associated 7-22 SCs into immunodeficient dystrophic mice generated 100 new 
multinucleated myofibers, which is equivalent to over 25,000 differentiated myonuclei 
(Collins et al., 2005).  Additionally, the newly formed tissue contained functional SCs 
that could complete another round of regeneration (Collins et al., 2005). A similar study 
used single SC transplantations, tracked by luciferase reporter activity, showed that SCS 
are capable of 14-17 doublings in vivo and supplies newly formed myofibers and self-
renewed Pax7 expressing SCs (Sacco et al., 2008).  These transplantation studies 
provided key evidence that SCs are able to give rise to differentiate progeny and self-
renew. 
The mechanism of SC self-renewal has been explored in several studies. SCs are 
positioned in a polarized environment when they establish quiescence with the apical side 
juxtaposed to the myofiber and basal side adherent to the basal lamina of the myofiber.   
Culturing single myofibers and their associated SCs allows for determination of the 
molecular fates of dividing SCs and their mitotic division plane orientation. SCs showed 
asymmetric expression of a Myf5 reporter during cell divisions when their division 
planes were perpendicular to the long axis to the myofiber (Kuang et al., 2008). SC 
divisions that are oriented parallel to the long axis of the cultured myofiber, planar 




Grand et al., 2009).  Interestingly, intravital imaging showed that SCs exclusively 
contacted the myofiber basement membranes during divisions suggesting that in 
physiological conditions, only planar divisions occur (Webster et al., 2016). Regardless, 
the molecular cues form the myofiber are important for self-renewal since Collagen VI, a 
component of the myofiber niche, is important for SC activation and self-renewal 
(Urciuolo et al., 2013).  All together these studies point to an important role for positional 
cues coming from tissue architecture to direct SC self-renewal during regeneration. 
The molecular components of self-renewal have been explored. A downstream 
target of RTK signaling, Sprouty1, is enriched during regeneration at the phase 
corresponding to reestablishment of quiescence and required for restoring the SC pool 
after injury. Constitutive Notch signaling in SCs promotes the Pax7+ fraction while 
reducing proliferation, thereby representing quiescent SCs in culture conditions (Wen et 
al., 2012). The polarity protein Mark2 (Par1b) is basally localized in activated SCs and 
regulates asymmetric division to promote the self-renewing population (Dumont et al., 
2015). The cell autonomous molecular properties of SCs have only begun to be explored. 
 
Quiescence and Activation of SCs 
SCs show low turnover during normal conditions and are typically quiescent. However 
reversible quiescence is critical for SCs to both provide cellular supply after injury and to 
reestablish quiescence when proliferative needs are met.  The self-renewed satellite cells 
form the source of SCs for future rounds of repair.  The loss of the ability to maintain a 
quiescent state, would therefore lead to unrestricted cellular proliferation or the depletion 




quiescence and activation are therefore key to the maintenance of SCs throughout the 
lifetime of the organism. 
Quiescence is an active process that requires proper maintenance at the level of 
transcription, post-transcriptional regulation, and chromatin structure.  Suv4-20h1 
dependent facultative heterochromatin restricts aberrant MyoD expression and cell cycle 
entry during quiescence to prevent aberrant activation during homeostasis (Boonsanay et 
al., 2016).  Inhibition of miR-31 by antagomiR tail vein treatment leads to increased 
Pax7+ cells and cell cycle entry which leads to more myonuclei and larger myofibers in 
the absence of injury (Crist et al., 2012). Calcitonin receptor restricts aberrant cell cycle 
entry of SCs and prevents emergence from the niche (Yamaguchi et al., 2015). Notch 
signaling component, RBP-J, prevents aberrant activation and progressive loss of the SC 
pool due to differentiation during quiescence (Bjornson et al., 2012; Mourikis et al., 
2012).  These key factors are important during quiescence to restrict the improper 
activation or differentiation of SCs in the absence of injury. 
The maintenance of quiescence is important during the resting phase to preserve the 
cellular pool. Upon injury, every SC that will give rise to a future SC will undergo at 
least one round of division (Troy et al., 2012).  Therefore, SCs quiescence must be 
reestablished from a proliferative population during regeneration.  Sprouty, which is 
important for renewing the Pax7 population during regeneration, also is essential for 
homeostasis of the replenished SC pool after injury (Shea et al., 2010). The forkhead 
transcription factor FOXO3 promotes self-renewal during regeneration by enhancing 




Reestablishing the SC population requires the restriction of proliferation and maintenance 
of an undifferentiated state within a population of transit amplifying myoblasts. 
Some of the key factors are important for maintaining quiescence during rest, regaining 
quiescence after activation, and promoting myoblast expansion are beginning to be 
revealed.  Growth factors are potent promoters of proliferation during regeneration.  
Insulin-like growth factor (IGF), hepatocyte growth factor (HGF), and fibroblast growth 
factor (FGF) fare released by myofibers and are required to stimulate myogenic 
proliferation during regeneration (Chakravarthy et al., 2000; Floss et al., 1997; Tatsumi et 
al., 1998).  Interleukin-6 (IL-6) is secreted by myoblasts and macrophages during injury 
to promote removal of necrotic tissue and synchronize proliferating myoblasts (Cantini et 
al., 1995). The robust proliferation of myoblasts is mediated by widely expressed growth 
factors. 
While the factors that mediate quiescence and activation have been uncovered, the 
potential for proliferation during the quiescent state has not been studied.  Whether and 
how a proliferative competent state co-exists with SC quiescence to permit cell cycle 
entry upon muscle injury is unknown.  Based on the rapid response of SCs to stimulus 
and the repressive role of quiescent factors implies that activation potential is present in 
the SC.  The outstanding question of how SCs are poised to activate yet remain quiescent 







































CREB mediated transcriptional control 
 The cAMP-response element binding (CREB) protein family of activators, 
consisting of CREB, ATF1 and CREM, is important for the execution of various 
transcriptional programs.  The leucine zipper (bZIP) domain and basic region impart 
selective dimerization and DNA binding, respectively, to all members of CREB 
transcription factors.  CREB regulates transcription of certain genes by binding to 
conserved promoter elements, cAMP response elements (CRE), as homodimers or 
heterodimers between CREB family members (Montminy and Bilezikjian, 1987; Short et 
al., 1986).  A dominant-negative inhibitor of CREB, termed A-CREB, was constructed 
by fusing an acidic extension onto the CREB bZIP dimerization domain.  Upon 
dimerization with A-CREB, CREB proteins are prevented from binding DNA to affect 
transcription (Ahn et al., 1998). In addition to its DNA binding domain, CREB contains a 
Ser133 phosphorylation site for PKA, which is stimulated by adenylyl cyclase (AC) via 
cAMP (Gonzalez and Montminy, 1989). Phospho-Ser-133-CREB interacts with 
p300/CBP, a histone-acetyltransferase (Bannister and Kouzarides, 1996; Ogryzko et al., 
1996) that recruits RNA polymerase II (Nakajima et al., 1997), to promote expression of 
downstream genes. 
  
 CREB signaling in myogenesis and muscle 
Previous work by our lab and others has shown that the CREB transcription factor 




previous study of CREB function during myogenesis found that adenoviral mediated 
expression of A-CREB, abolished myogenic gene induction in cultured embryos (Chen et 
al., 2005). In cultured myoblasts, crushed muscle extracts increased pCREB levels and 
canonical CREB target gene induction (Stewart et al., 2011). Mice expressing an 
activation-sensitive form of CREB (CREB-YP) showed increased general cell 
proliferation after muscle injury (Stewart et al., 2011). Given that CREB activity also 
prevents muscle fiber death directly and promotes muscle repair indirectly via M2 
macrophages (Berdeaux et al., 2007; Ruffell et al., 2009), the general proliferation 
increase in CREB-YP injured muscle likely has multiple origins. Furthermore, the SCs of 
CREB-YP mice were not examined nor were regeneration outcomes.  As extensive as 






Differential CREB activity is detected during myogenic progression of SCs 
To gain insight into whether CREB activity might operate during adult 
myogenesis, I conducted a thorough characterization of CREB activity in adult SC and its 
descendants during myogenic progression by immunofluorescence detection of pCREB. 
In uninjured tibialis anterior (TA) muscle, pCREB was detected in 97% of SCs (stained 
positive for the definitive marker Pax7, Pax7+; Figure 1), suggesting an active role for 
CREB during quiescence. 
I next examined how pCREB pattern might change after SC activation. For this, I 
assessed pCREB levels in SCs associated with myofibers at various time points in 
culture. For identification of SC lineage, we isolated myofibers with YFP marked SCs 
from tamoxifen (TAM) treated Pax7CE/+;Rosa26YFP/YFP mice (Figure 2). Immediately 
upon isolation pCREB was detected in 98% of YFP marked SCs (time 0, T0; Figure 3B), 
in agreement with in vivo pCREB levels of quiescent SCs in uninjured muscles (Figure 
1). SCs displayed changed levels of pCREB over 2 days (Figure 3A,B). Using average 
pCREB fluorescence signal intensity of associated myonuclei as a reference, I observed 
the SC fraction with high pCREB (>1.5X of myonuclear signal) gradually declined, 
whereas fractions with low or virtually non-detectable/negative pCREB (1.5-0.5X or 
<0.5X of myonuclear signal, respectively) increased (Figure 3B). 
I also assessed pCREB levels in SC-derived primary myoblasts. Unsynchronized 
differentiation of this population allowed assessment of pCREB levels in Pax7+, MyoD+, 
Mgn+, or MHC+, each representing a progressively more differentiated state. Pax7+ and 




and MHC+ cells had high levels of pCREB (Figure 4A,B). These data extend the prior 
report showing enhanced pCREB levels in myoblasts after exposure to crush muscle 
extract (Stewart et al., 2011) by demonstrating that CREB activity is present in quiescent 








 Characterization of temporal pCREB levels reveals differential CREB activity 
during quiescence and early activation.  Prior observations (Stewart et al., 2011) found 
that pCREB was present in proliferating myoblasts, however my study of the kinetics of 
CREB activity during early activation revealed CREB activity during quiescence as well 
as activated cells.  Additionally, I found that pCREB activity was enriched in 
undifferentiated myoblasts compared to terminally differentiated myoblasts.  This could 
be assessed through co-staining of terminal differentiation markers Mgn and MHC 
(Figure 3A,B) or by comparing the fluorescence intensity of the SC/myoblast to its 
neighboring myonuclei.  The lack of CREB activity in terminally differentiated 
myoblasts/myotubes is a bit counterintuitive considering the requirement of CREB 
activity in maintaining mature myofibers (Berdeaux et al., 2007).  However, the study by 
Berdeaux et al. tested the role of CREB in maturated muscle fibers.  The study utilized a 
promoter skeletal muscle actin was used to drive A-CREB in adult myotubes that contain 
hundreds of myonuclei and have structural requirements that may not be required for 
newly differentiated cells in culture. In summary these data suggest a novel role for 
CREB during the quiescent state as well as during early activation. 








Figure 1. CREB is activated in quiescent SCs (A) TA muscle sections of 2 month old 
CD1 wild-type mice. SCs (Pax7+) express pCREB+.  (B) Double positive satellite cells 
(white arrow) were quantified as a percentage of total Pax7+ cells. N=3 mice, n≥50 cells 






















Figure 2. Alleles used for spatial and temporal expression of YFP and A-CREB in 
the Pax7+ lineage  (A) Schematic illustrating Pax7CE allele and resultant genotypes upon 










Figure 3. CREB is activated in quiescent SCs and activated myoblasts EDL single 
fibers and associated SCs of YFP mice were harvested for immediate fixation or cultured 
in plating medium for 0.5, 1, and 2 days and then fixed for immunostaining.  (A) 
Representative images of pCREB fluorescence intensity (high, low and negative) at 0.5 
days after harvest.  Dotted line marks myoblast nuclei, white arrow marks myofiber 
nuclei, number indicates pCREB+ integrated density (I.D.) normalized to myofiber nuclei 
pCREB I.D.  (B) Quantification of pCREB I.D. shows pCREB expression declines over 
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Figure 4. CREB is enriched in Pax7+ cells and reduced in differentiated cells (A) 
Primary CD1 myoblasts cultured in growth media were assessed for coexpression of 
pCREB and Pax7, MyoD, Mgn or MHC.  Pax7+ myoblasts express various pCREB 
levels.  Pax7(low)/pCREB(low) (white asterisk) and Pax7(high)/pCREB(high) myoblasts 
(red asterisk) were observed.  Mgn (green arrow) and MHC (yellow arrow) myoblasts 
showing absence of pCREB expression. Green and yellow arrowheads indicate Mgn and 
MHC negative cells, respectively, which serve as as internal positive controls for pCREB 
expression. (B) Coimmunostaining of pCREB with Pax7 and differentiation markers 
MyoD, Mgn, MHC show a significant negative association between pCREB versus 










Three month old, CD1 wild-type or Pax7CE/+Rosa26YFP/YFP were used.  Appropriate 
mating schemes were performed to obtain Pax7CE/+Rosa26YFP/YFP mice.  Animal treatment 
and care conform to the requirements of the Carnegie Institution and NIH guidelines. 
Tibialis anterior (TA) cryosections  
Animals were sacrificed by cervical dislocation.  TA muscle was immediately dissected 
and fixed in ice cold 4% paraformaldehyde, EM grade catalog #15710, Electron 
Microscopy solution, diluted in 1XPBS for 10 minutes.  After two washes in ice cold 
1XPBS, muscle was subjected to two sucrose treatments, 10% sucrose in PBS and 20% 
sucrose in PBS for 8-12 hours each.  Cryoprotected TA muscle was mounted onto cork 
slices using tragacanth (1:2::tragacanth:water), catalog # G1128, Sigma.  Mounted 
muscle was submerged in liquid nitrogen cooled isopentane bath for 45 seconds and 
stored at -80 oC until sectioning. Sections were obtained using Leica cryostat set at -21 oC 
using 12 µm increments for collecting sections onto Superfrost glass slides, catalog #12-
550-15, Fisherbrand. 
Single fiber isolation 
For immediate fixation, T0 fibers, extensor digitorum longus (EDL) muscles were 
digested in 0.6% Collagenase, catalog #C0130, Sigma/1XDMEM, catalog #11995-073, 
Invitrogen, for 15 minutes in 37oC shaking water bath.  Using a fire-polished, horse 
serum coated, wide aperture glass pipette, single fibers were dissociated from EDL 




For single fiber cultures, EDL muscles were digested in 0.2% Collagenase for 1.5 
hours and then transferred to 37oC DMEM.  Using a fire-polished wide aperture glass 
pipette, single fibers were dissociated from EDL muscle by gentle trituration for 1-2 
hours and transferred to fresh culture media. 
Myoblast isolation 
Hindlimb muscle was minced and then digested in 0.2% Collagenase for 1.5 hours and 
then 0.2% Dispase, catalog #17105-041, Invitrogen, (20 mL enzyme solution per mouse) 
for 20 minutes.  Cells were washed twice by spinning and removing cell debris by 
vacuum aspiration and resuspended in 1XDMEM for washes.  Cell pellet was 
resuspended in 1XDMEM and filtered through 40µm cell strainer and spun.  Cell pellet 
was resuspended in culture media for transfer to matrigel coated (1:100 dilution in 
DMEM), catalog #356234, BD Biosciences, tissue culture plates. 
Tissue culture 
Floating myofibers were cultured on horse serum coated 3.5cm tissue culture dishes in 
plating media (10% horse serum, 0.5% chicken embryo extract, 1XPENSTREP, 1% 
Glutamax). Myoblasts were cultured on matrigel, (1:100 dilution in DMEM), catalog 
#356234, BD Biosciences, coated tissue culture plates in, growth media (20% fetal 
bovine serum, 5% horse serum, 1% chicken embryo extract, PENSTREP, 1% Glutamax, 
bFGF). 
Antibodies 
Primary antibodies were mouse IgG1 anti-Pax7 (1:5), DSHB; rabbit anti-pCREB-ser133 
(1:1000), catalog # #9198 (87G3); chicken anti-laminin (1:50), catalog #ABIN573807, 




Labs; rabbit anti-MyoD (1:500), catalog #sc304, Santa Cruz; mouse anti-Mgn IgG1 
(1:20), catalog #F5D, DSHB, mouse anti-MHC IgG2b (1:20), catalog #MF20, DHSB.  
Secondary antibodies (all used at 1:500) were goat anti-mouse IgG1, Alexa Fluor 568, 
catalog #A21124, Invitrogen; goat anti-rabbit, Alexa Fluor 488, catalog #A11034, 
Invitrogen; goat anti-chicken, Alexa Fluor 647, catalog # A21449; goat anti-rabbit, Alexa 
Fluor 568, catalog #A11011, Invitrogen; goat anti-chicken Fluorescein, catalog #F1005, 
Aves Labs. 
Immunostaining  
Collected sections were dried at room temperature for 15-30 minutes.  PAP pen, catalog 
#100491-772, was used to delineate create a hydrophobic boundary around sections to 
contain solutions.  Sections were fixed with ice cold 4% paraformaldehyde, EM grade 
catalog #15710, Electron Microscopy solution, diluted in 1XPBS for 10 minutes and 
washed twice in PBST (0.05% Triton X-100/1XPBS).  Sections were permeabilized in 
0.3% Triton X-100/1XPBS for 30 minutes and washed twice in PBST before blocking 
overnight in 3.2% M.O.M. block/PBST, catalog #BMK-2202, Vector Laboratories at 
4oC. After 2 washes in PBST, a second block in normal goat serum (NGS) based 
blocking buffer (10% normal goat serum, 1%(w/v) blocking powder, catalog #pc2307-
1001 FP1020, PerlinElmer Life Sciences, 0.05% Triton X-100, in 1XPBS) was 
performed for 30 minutes.  
Single fibers were fixed in 37oC 2% PFA, EM grade for 10 minutes.  PBST 
washes were performed by removing PFA solution and adding PBST at 1:5 serially three 




to horse serum glass staining dish and permeabilized using 0.3%Trition X-100/1XPBS 
for 30 minutes and then washed twice with 1XPBST. 
Primary antibody was diluted in NGS-based blocking buffer and applied to 
sections or fibers overnight at 4oC.  After 3 PBST washes, 5 minutes per wash, NGS-
based blocking buffer diluted secondary antibody was applied to sections for 30 minutes.  
DAPI counterstain and 2 additional washes in PBST was performed before mounting in 


































Choreographed Muscle Regeneration 
SCs are the main cellular source for new myofiber formation (Lepper et al., 2011; 
Murphy et al., 2011; Sambasivan et al., 2011). Muscle repair is a highly regulated process 
that requires proper activation of SCs for building the cellular source for myofiber 
formation and SC self-renewal.  SCs enter a transit amplification phase in which SCs 
undergo cell divisions and begin to fuse into new myofibers.  Myocytes migrate into an 
organized linear pattern then fuse to form the multinucleated myofiber (Knudsen et al., 
1989; Mintz and Baker, 1967; Yaffe and Feldman, 1965).  After fusion, myofibers will 
begin to grow in size to reestablish the original muscle mass prior to injury (Chargé and 
Rudnicki, 2004).  A portion of proliferating myoblasts will exit the cell cycle, express 
Pax7, and return to the myofiber niche to serve as a reserve population for future rounds 
of injury (Fan et al., 2012). 
Biological sources for initiation of the muscle regeneration program are disease 
and injury.  Duchenne muscle dystrophy is an X-linked recessive form of muscular 
dystrophy that is characterized by structurally defective myofibers that undergo cyclic 
rounds of regeneration and degeneration (Hoffman et al., 1987).  Traumatic damage by 
intense exercise such as weight lifting and eccentric exercise can also induced muscle 
regeneration (Armstrong et al., 1983; Singh et al., 1999).  To generate consistent and 
robust injuries in controlled experiments, chemical based toxins such as CTX, notexin 
and barium chloride can be locally injected into skeletal muscle to produce muscle injury.  











Genetic strategy to selectively inhibit CREB activity in adult SCs  
Forced expression of A-CREB, a potent and selective inhibitor of CREB activity, is 
routinely used in in vivo systems to study CREB function (Ahn et al., 1998b; Herzig et 
al., 2001; Riccio et al., 1999).  Our lab has previously generated a functional mouse 
allele, Rosa26A-CREB, for Cre-dependent A-CREB expression and bicistronic nuclear GFP 
(nGFP) cell marking (Figure 2A; Lopez and Fan, 2013). After combining this allele with 
the inducible Pax7CE driver (Figure 2A), we could detect nGFP expression in 95% of SCs 
after tamoxifen administration (Figure 5A,B,C), similar to the cell marking efficiency in 
Pax7CE;Rosa26YFP control mice (Figure 5A,B,C). Mice with SC specific A-CREB (SCA-
CREB) expression did not show altered Pax7+ SC number immediately nor over the long-
term (Figure 6A,B).  To further investigate the maintenance of the SC population, I tested 
the expression pattern of β1-integrin and found no disturbance of basal localized 
expression in SCsA-CREB (Figure 7A,B).  Additionally, break of quiescence was not 
detected when following EdU incorporation SCsA-CREB for 3 weeks (Figure 7A,B), which 
is one week longer than experiments by other groups that found spontaneous proliferation 
of mutants (Bjornson et al., 2012; Boonsanay et al., 2016; Cheung et al., 2012; Crist et 
al., 2012; Mourikis et al., 2012; Yamaguchi et al., 2015).  The preservation of Pax7+ cell 
number, localization within the niche, and maintenance of quiescent indicates that CREB 
activity is not required to maintain the SC population during quiescence. 




Because Pax7+ and MyoD+ myoblasts showed high pCREB levels, I postulated that 
CREB might have a role in progenitor expansion after SC activation. I therefore 
examined muscle regeneration in mice after cardiotoxin (CTX)-induced injury (Figure 8). 
At 5 and 10 days (d) post-injury, SCA-CREB mice showed significant reductions in 
regenerated myofiber number and diameter by histology and MHC immunofluorescence 
(Figure 9A, 10A,B). At 35 d post-injury, the few regenerative fibers at earlier time points 
were no longer detectable in SCA-CREB mice (Figure 11), consistent with CREB’s role in 
maintaining mature myofiber survival (Berdeaux et al., 2007). 
When I assessed the Pax7+ population at 5 and 10 d post-injury, SCA-CREB mice 
showed over 90% fewer Pax7+ cells compared to controls (Figure 12). No Pax7+ cells 
were observed in damaged areas 35 d post-injury (Figure 11). Because of the lack of new 
myofibers, the absence of SCs at 35 d may be due to unavailable myofiber niches.  These 
results indicate that inhibiting CREB in SCs leads to loss of Pax7+ SCs after injury, 







The success of regeneration depends on the proper response of SCs to injury stimulus.  I 
found that CREB activity has a distinct role in the regenerative capacity of SCs and 
muscle regeneration.  While CREB inhibition in the SC does not cause stem cell defects 
in terms of survival, cell fate, nor quiescence, once challenged by injury, SCsA-CREB do 
not respond correctly to injury stimulus. CREB inhibition leads to drastically reduced 
myofiber formation (Figure 9A, 10A,B).  Newly formed fibers are smaller and fewer are 
formed, indicating either lack of myocytes fusion or lack of SC proliferation.  Because I 
didn’t see an abundance of nGFP positive cells in the interstitial space (Figure 10), , I 
predicted that the inability to form new fibers could be caused by lack of a sufficient 
progenitor pool rather than a lack of ability to fuse.  Because a few fibers do form, a 
fusion defect likely does not explain the severe inability to regenerate new fibers.  
SCs must also self-renew its population to provide a source of stem cells for 
future rounds of regeneration.  The number of Pax7+ cells at 5 and 10 days after injury 
were significantly reduced upon A-CREB expression in the SC lineage.  Day 5 is a time 
point in which a portion of proliferating progenitors have fused to form terminally 
differentiated myofibers although a portion of myoblasts are proliferating in the 
interstitial space.   At this time point, myoblasts represent both the transit amplifying 
population as well as the cellular population that will go on to form the reserve SC pool.  
I found that the number of Pax7+ cells was significantly reduced, indicating a lack of 
expansion of progenitors and/or self-renewing SCs.  A further reduction in Pax7+ cells at 




expansion.  Further, day 10 after regeneration, SCs will begin to reenter the niche and 
reestablish quiescence.  In A-CREB expressing myoblasts, very few SCs are present 
compared to control (Figure 12A,B) suggesting A-CREB mice cannot self-renew the SC 









Figure 5. YFP and nGFP labeling efficiency in the Pax7-lineage (A) Timeline 
depicting tamoxifen injection regiment and TA muscle harvest 5 days after tamoxifen 
treatment. (B) Pax7 expression in lineage marked tamoxifen treated YFP and A-CREB 
mice at day 5 post-tamoxifen treatment as depicted in (A). (C) Quantification of labeling 
efficiency by determining YFP or nGFP expression in Pax7+ cells in YFP or A-CREB 
mice, respectively, by immunofluorescence. Scale bars 50µm. N=3 mice, n≥50 cells per 






















































Figure 6. CREB inhibition does not affect Pax7+ cell number during quiescence (A) 
Timeline depicting tamoxifen injection regiment and TA muscle harvest at 5 and 35 days 
after tamoxifen treatment. (B) Maintenance of Pax7 expression was assessed by 
determining Pax7 expression in lineage marked cells at day 5 and day 35 and total 
number of Pax7 positive cells per area at day 5 and day 35 after tamoxifen treatment. 























































































































Figure 7. CREB inhibition does not disrupt basal domain nor quiescence of SCs 
Representative images of ITGB1 expression and EdU detection analyzed by 
immunofluorescence in uninjured TAM treated TA muscle of YFP and A-CREB mice.  
Daily EdU injections performed during 5 days of TAM treatment and 2.5 weeks after last 
TAM injection. Boxed region is enlarged below.  Dotted line marks basal lamina edge of 
myofiber. Arrowhead indicates apical side of SC. Scale bars 30 µm (top row), 10µm 
























































Figure 9. CREB inhibition leads to drastically reduced regeneration of myofibers 
after CTX injury (A) Hematoxylin and Eosin histological sections 5 days after 
cardiotoxin injury of YFP (control) and A-CREB TA muscles.  Dotted line (left panels) 
demarcate uninjured area on the left and regenerated area on the right.  Boxed region in 
left panel is enlarged in the right panel.  Black arrows indicate newly formed centrally 




















Figure 10. CREB inhibition leads to significantly reduced newly formed myofiber 
number and myofiber size after CTX injury (A) Representative images of embryonic 
myosin heavy chain (MHC) expression analyzed by immunofluorescence at day 5 and 
day 10 after injury. (B) Quantification of MHC+ myofibers per indicated area (left) and  
average myofiber diameter (right) at day 5 and 10 after injury. Data represented as mean 
+/- 1 standard deviation. ***p<0.001, p<0.01, Student’s t-test. Scale bar 50µm. 
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Figure 11. CREB activity is required for myofiber maintenance and Pax7+ cell 
maintenance after injury (A) Schematic illustrating tamoxifen treatment and day 35 
muscle injury regiment. (B) Representative images of Pax7 expression analyzed by 
immunofluorescence at day 35 after injury.  Arrow indicates Pax7+ cell. (C) 
Quantification of MHC+ cells per indicated area at day 35 after injury. (D) Quantification 
of MHC+ cells per indicated area at day 35 after injury. Data represented as mean +/- 1 











































































Figure 12. CREB inhibition leads to loss of Pax7+ cells during regeneration (A) 
Representative images of Pax7 expression analyzed by immunofluorescence at day 5 and 
day 10 after injury.  Arrows indicated Pax7+ cells. (B) Quantification of Pax7+ cells per 
indicated area at day 5 and 10 after injury. Data represented as mean +/- 1 standard 
deviation. ***p<0.001, Student’s t-test. Scale bar 50µm. 
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Appropriate mating schemes were performed to obtain Pax7CE/+Rosa26YFP/YFP and  
Pax7CE/+Rosa26A-CREB/A-CREB mice.  Animal treatment and care conform to the 
requirements of institution and NIH guidelines. 
Tamoxifen solution 
Tamoxifen, catalog #T5648, Sigma, was prepared for intraperitoneal injections by 
dissolving in corn oil, catalog #C8267, Sigma, at 20 mg/mL.  The mixture was incubated 
in a 37oC shaker at high RPM.  Tamoxifen was dissolved within 30-90 minutes and 
aliquoted into 10mL volumes and flash frozen in dry ice chilled EtOH.  Frozen aliquots 
were stored at -80oC until use.  Thawed aliquots were stored at 4oC for up to two weeks. 
Tamoxifen injections for inducible Cre activation 
250 μL of 20 mg/mL tamoxifen in oil solution was injected daily for 5 consecutive days 
intraperitoneally into adult mice using a 26 gauge needle.   
EdU treatment 
200 μL of 0.5 mg/mL EdU solution was injected intraperitoneally into mice daily for 3 
weeks. 
Cardiotoxin treatment 
Cardiotoxin (CTX), catalog #C9759, Sigma, was resuspended in 1XPBS 10 μM and 
aliquoted into 1.5 mL Eppendorf tubes and flash frozen in dry ice chilled EtOH.  Frozen 
aliquots were stored at -80oC until use.  Prior to injection, animals were anesthetized 




μl/gram body weight of 20 mg/ml solution). TA muscles were injected with 50 μL of 
CTX using an insulin needle (1/10 mL), catalog #14-829-26, Fisher.   
Tibialis anterior (TA) cryosections  
See Chapter 2 for methods used for obtaining TA muscle cryosections. 
Single fiber isolation 
See Chapter 2 for methods used for obtaining single fibers. 
Antibodies 
Primary antibody used were rabbit anti-GFP monoclonal (1:500), catalog # G10362, 
Invitrogen; rat anti-Integrinβ1 (1:1000), catalog #MAB1997, Millipore. Secondary 
antibody used were goat anti-rat AlexaFluor 488 (1:500), catalog #A11077.  See Chapter 
2 for additional antibodies used. 
Immunostaining 
See Chapter 2 for methods used for immunostaining muscle tissue sections. 
EdU detection 
Primary and secondary antibody protocol was performed prior to EdU detection.  After 
secondary antibody application, Click-iT EdU Alexa-Fluor 647 Imaging Kit, catalog 
#C10085, Invitrogen, was used following manufacture’s suggested protocol.    
Hematoxylin and Eosin staining 
Muscle sections were fixed in ice cold 4% paraformaldehyde for 10 minutes and rinse in 
distilled water for 1 minute.  Sections were incubated in Hematoxylin, catalog #01560, 
Surgipath, for 3.5 minutes and then rinse in running lukewarm tap water for 5-10 
minutes.  Sections were then incubated in Scott’s tap, catalog #3802901, Leica 




Sections were stained in Eosin, catalog #01600, Surgipath, for 1 minute and dehydrated 
in EtOH series: dip 5 times in 95% EtOH, dip 5 times in newly made solution of 95% 
EtOH, dip 30 times in 100% EtOH, dip 30 times in xylene.  Sections were mounted under 



































Myoblast proliferation during regeneration  
Upon injury, SCs undergo proliferation and then differentiation to generate new 
myofibers (Moss and Leblond, 1970; Snow, 1978).  The proper timing of both of these 
events is crucial for generating sufficient, but not excessive myoblasts.  The first SC 
division after injury can begin as early as 24 hours after injury induction (Zammit et al., 
2002).  Subsequent cell cycles can be more rapid with a cycling time of about 12 hours 
being average (Zammit et al., 2002).  From day 0 to day 3 of regeneration, SC derived 
myoblasts are primarily proliferative with only a small portion of cells showing 
differentiation (Zammit et al., 2004).  This allows for expansion of the progenitor pool 
for supplying the future myonuclei of the regenerated myofibers.  After 3 days, the 
terminal differentiation markers Mgn and MHC begin to appear (Zammit et al., 2004).  
The beginning of myofiber formation coincides with further myoblast proliferation, 
however as proliferation ceases, myocyte fusion dominates and myocytes are largely 








CREB activity is necessary for SC proliferation 
To determine whether the reduction of Pax7+ SCA-CREB cells at 5 d post-injury (Figure 
12B) is due to defective proliferation, I examined the rate of in vivo EdU incorporation 
during muscle repair from day 0 through 5 after CTX injury (Figure 13A). I observed a 
marked reduction in SCA-CREB proliferation, compared to robust expansion of control 
YFP+ SCs during the 2-5 d period, when assaying for total lineage marked cells and for 
percent of cells incorporating EdU at each time point (Figure 13B,C). I next tested 
whether precocious differentiation might contribute to failed expansion. Indeed, the 
fraction of lineage marked SCs positive for the myocyte marker Mgn at 2-4 days post-
injury were significantly higher in SCA-CREB mice compared to controls (Figure 14). To 
further test SCA-CREB proliferative performance and differentiation kinetics, I used 
myofiber culture assays, in which injury is absent.  The majority of SCsA-CREB remained 
as single cells after 3 d in culture, while most control SCs expanded to form multi-cell 
clusters (Figure 15). At 1 d, when most cells had not undergone cell cycle, single SCsA-
CREB expressed Mgn, while control SCs did not (Figure 16), indicating that at least a 
portion of SCsA-CREB undergo differentiation without cell division. Consistent with our in 
vivo studies, these findings demonstrated that SCsA-CREB proliferate poorly and 
differentiate early during the expansion phase. 
Reduced SC expansion explains fewer newly regenerated myofibers in SCA-CREB 




efficiency. To test this possibility, I purified SCsA-CREB and control SCs by fluorescence 
activated cell sorting (FACS) based on GFP/YFP signal, and plated them at the same 
density in differentiation media. I found SCsA-CREB showed similar fusion efficiency as 
controls (Figure 17). Together, the findings provide evidence that SCsA-CREB are defective 
in proliferation but capable of transitioning through the differentiation program to form 









Expression of A-CREB in the SC causes significantly reduced ability to mount a 
proliferative program.  The lack of proliferation explains the observed regeneration 
phenotype in which newly regenerated myofibers were reduced as well as their size 
(Figure 9,10). This indicates that CREB activity promotes a proliferation factor and since 
few SCsA-CREB expanded or incorporated EdU throughout the expansion period, it is likely 
that the proliferation defects occurs early.  Additionally, myoblast begin to terminally 
differentiate as early as 1 day after activation (Figure 16), which is usually when the first 
cell division occurs.  These suggest that the first division of SCsA-CREB is defective which 
leads to loss of an amplifying progenitor pool. 
 I ruled out the possibility that SCsA-CREB were lost to apoptosis based on their 
survival after short and long term tamoxifen treatment (Figure 6) as well as their ability 
to form myofibers in culture without noticeable loss of total cell number (Figure 17).  I 
assayed the differentiation marker Mgn in the A-CREB expressing myoblast population 
and found a greater percentage of myoblasts had entered terminal differentiation 
compared to control.  This indicated that the loss of proliferation coincides with 
accelerated differentiation.  Loss of RBP-J kappa in SCs also results in accelerated 
differentiate however these mutant cells also break quiescence and fuse into existing 
myofibers without injury (Bjornson et al., 2012; Mourikis et al., 2012).  This indicates 
that SCsA-CREB defects likely do not involve Notch signaling completely. The events that 
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Figure 13. CREB is required for proper SC proliferation (A) Schematic illustrating 
tamoxifen treatment and EdU injections used for day 0,2,3,4 and 5 muscle injury 
regiments. (B) Representative images of EdU incorporation detection in YFP and A-
CREB TA muscle at indicated time points after CTX injury. Arrows indicate lineage 
marked EdU- myoblasts and arrowheads indicated lineage marked EdU+ myoblasts. (C) 
Quantification of YFP and A-CREB lineage-marked myoblast number and EdU+ 
myoblast number on day 0,2,3,4, and 5 after CTX injury. Data represented as mean +/- 1 









Figure 14. CREB inhibition leads to premature differentiation (A) Representative 
images of Mgn expresion in YFP and A-CREB myoblasts from TA muscle at 4 days 
after CTX injury. Arrows indicate lineage marked Mgn+ myoblasts. Arrowheads indicate 
lineage marked Mgn- myoblasts. (B) Quantification of Mgn+ cells as a percentage of total 
GFP+ lineage marked myoblasts. Data represented as mean +/- 1 standard 










          
          
   
   
   
           
          
   
   











































cells within clonal cluster 
** B 
Figure 15. CREB inhibition in the SC leads to reduced proliferation in vitro (A) 
Representative images of YFP and A-CREB myofiber-associated myoblast clusters after 
3 days of culture in plating medium.  Arrows indicated lineage marked DAPI+ myoblasts 
from within a cluster. (B) Quantification of cluster size after 3 days of culture in plating 
medium. Data represented as mean +/- 1 standard deviation. *p<0.05, **p<0.01, 




















Figure 16. CREB inhibition leads to premature differentiation at the expense of 
Pax7+ cell maintenance in vitro (A) Immunofluorescence of single myofiber-associated 
SCs cultured in plating medium for 1 day shows A-CREB SCs undergo premature 
differentiation.  Green arrows mark Mgn- SCs.  White arrows mark Mgn+ SCs. (B) 
Quantification of Pax7, MyoD or Mgn expression shows A-CREB SCs have reduced 
Pax7 and enhanced Mgn. N=3 mice/genotype, n≥100 cells/animal.  Data represented as 









Figure 17. CREB is not necessary for terminal differentiation (A) YFP and A-CREB 
satellite cells were purified by FACS and plated at equal densities for 5 days in DM. 
Immunofluorescence analysis of MHC expression shows proper myofiber formation by 
A-CREB satellite cells. (B) Quantification of fusion index shows A-CREB myoblast 
differentiation is comparable to control. N=3 technical replicates, n≥200 cells/replicate. 
































See Chapters 2 and 3 for mice used. 
Tamoxifen injections for inducible Cre activation 
See Chapter 3 for methods used for tamoxifen injections. 
Tibialis anterior (TA) cryosections  
See Chapter 2 for methods used for obtaining TA muscle sections. 
Single fiber isolation 
See Chapter 2 for methods used for obtaining single myofibers. 
EdU treatment 
200 μL of 0.5 mg/mL EdU solution was injected intraperitoneally into mice 24 hours 
prior to harvesting muscle tissue for analysis. 
Cardiotoxin treatment 
See Chapter 3 for methods used for cardiotoxin injury. 
EdU detection 
See Chapter 3 for methods used for detecting EdU incorporation. 
Antibodies 
See Chapter 2,3 for methods used for antibodies used. 
Fluorescence activated cell sorting (FACS) 
SCs of hindlimb muscle from TAM treated YFP and A-CREB mice were isolated in the 




resuspended in 1XPBS prior to enrichment by positively selecting for YFP or nGFP 
signal in lineage marked SCs by FACS. 
Tissue culture 
FACS sorted myoblasts were cultured on matrigel (1mg/10mL dilution in DMEM), 
catalog #356234, BD Biosciences, coated Permanox tissue culture slides, catalog 
#62407-335, VWR Scientific, in differentiation media (10% horse serum, PENSTREP, 



































The capacity of SCs to self-renew is evident in their ability to regenerate muscle after 
multiple rounds of injury.  Two studies suggest a role for CREB in cell fate decisions.  
First, embryonic CREB mutants showed decreased expression of Pax3 (a paralog of 
Pax7) and MyoD in myogenic progenitors (Chen et al., 2005).  Second, germline 
expression of an activation sensitive form of CREB, CREB-YF, resulted in greater levels 
of Pax7 protein in myoblasts between 6-12 hours of culturing in differentiation media 
(Stewart et al., 2011). The inability to regain Pax7+ cells during regeneration (Figure 12) 
and the lack of proliferation of SCs after injury (Figure 13) promoted me to investigate 
the self-renewal capability of SCs. The role of CREB in cell fate regulation suggests the 







SCsA-CREB have a defect in self-renewal 
Reduced Pax7+ cells after injury in SCA-CREB mice suggests a SC self-renewal defect 
caused either directly by A-CREB expression in the SCs and/or secondarily by deficient 
newly formed myofiber niches and inadequate environmental conditions of poorly 
regenerated areas. The myofiber culture assay permits SC self-renewal examination 
within wild-type niches and adequate milieu (Day et al., 2007; Zammit et al., 2004). By 
assessing the fractions of lineage marked Pax7+MyoD- (self-renewed), Pax7+MyoD+ 
(expanding progenitors), and Pax7-MyoD+ (committed progenitors) cells 4 d after 
activation, I found that the SCA-CREB lineage had reduced fractions of expanding 
progenitors and renewed SCs (Figure 18A,B). Furthermore, I found that FACS purified 
SCsA-CREB generated fewer Pax7+ reserve cells compared to controls in 5 d differentiated 
cultures (Figure 19A,B). As reserve cells are suggested to be similar to quiescent SCs, 
SCsA-CREB may be defective in re-acquiring quiescence.  
I next examined SC symmetric versus asymmetric divisions by probing for Pax7, 
MyoD or Mgn expression after the first cell cycle in myofiber cultures.  In 2 d cultures, 
80% of control SCs divided once to form doublets, whereas only 23% of A-CREB 
clusters were doublets (Figure 20). Over 80% of control doublets contained at least one 
Pax7+ daughter, conversely over 80% of A-CREB daughters were both Pax7- (Figure 
21B). Both YFP and A-CREB doublets were mostly MyoD+ (Figure 21B). Notably, many 
A-CREB doublets contained daughters that were both Mgn+, whereas this combination 




renewal occurs in the first cell division (Troy et al., 2012), these data show that the small 
fraction of SCsA-CREB that divide have a high propensity towards differentiation and 
limited self-renewal. All together, I conclude that CREB activity maintains the Pax7+ SC 







Self-renewal is a hallmark characteristic of SCs, which enables multiple rounds of muscle 
repair throughout the lifetime of the organism. CREB inhibition in the SC abolishes the 
capacity to maintain the Pax7+/MyoD- self-renewing population as well as the 
Pax7+/MyoD+ progenitor population after activation (Figure 18).  This occurs on single 
fiber cultures in which the myofiber niche is not disrupted by damage and has not 
incorporated defective myoblasts.  This shows that the SCA-CREB defect in vivo (Figure 9, 
10,11,12,13,14) is not merely a secondary effect of disrupted myofibers and altered 
niche. Consistently, FACS purified A-CREB expressing cultured myoblasts could not 
reform the reserve cell phenotype (Figure 19). Therefore, the requirement for CREB in 
the ability to re-establish the Pax7+ lineage is likely cell autonomous.   
 Upon activation, SCs are thought to be a heterogeneous mixture of myoblasts that 
have differential propensities towards self-renewal or differentiation (Kuang et al., 2008).  
In a recent study to determine when the SC might be commited for self-renewal, the 
authors found that SCs that regained quiescence at 4 days after activation (the reserve cell 
phenotype) were set aside during the first cell division (Troy et al., 2012).  The inhibition 
of CREB in the SC prior to activation led to mostly an inability to expand (Figure 20), 
and those SCs that did undergo one cell division had high propensity to differentiation 
rather than self-renew (Figure 21).  The direct terminal differentiation without 
proliferation explains some of the reason why few cells divide (Figure 16).  Both the 
inability to proliferate as well as the accelerated differentiation rate of SCsA-CREB 








Figure 18. CREB inhibition leads to loss of Pax7 self-renewal after activation (A) 
Single myofiber-associated SCs were cultured for 4 days. Immunofluorescence analysis 
of myoblasts within clonal clusters. Red and green arrows mark Pax7+MyoD- and Pax7-
/MyoD+ myoblasts, respectively. Asterisks mark Pax7+MyoD+ myoblasts. (B) 
Quantification of Pax7 and MyoD expression pattern shows few SCsA-CREB renew the 
Pax7+/MyoD- population after activation. N=3 mice/genotype, n≥150 cells/animal. 
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Figure 19. CREB inhibition leads to loss of Pax7+ reserve cell population (A) YFP 
and A-CREB expressing SCs were purified by FACS and plated at identical densities for 
5 days in DM. Immunofluorescence analysis of Pax7 shows reduced Pax7+ population in 
SCsA-CREB.  Arrows mark Pax7+ myoblasts. (B) Quantification of Pax7+ cell number after 
differentiation shows SCsA-CREB reestablish fewer Pax7+ reserve cells. N=3 technical 
replicates, n≥200 cells/replicate. Data represented as mean +/- 1 standard deviation. 


































Figure 20. Proliferative cluster profile of SCs after 2 days in culture Quantification 
of cell number within myofiber-associated YFP and A-CREB myoblast clusters 2 days 







































Figure 21. CREB inhibition leads to loss of Pax7+ expression after the first cell 
division (A) EDL myofibers and associated SCs were cultured for 2 days in plating 
media. Immunofluorescence analysis of myoblast doublets. Mgn expression within 
myoblast doublets shows increased frequency of Mgn expression by SCsA-CREB.  White 
and red arrows mark Mgn- myoblasts and Mgn+ myoblasts, respectively. (B)  
Quantification Pax7, MyoD, or Mgn expression within doublets. N=3 




























































See Chapters 2 and 3 for mice used. 
Single fiber isolation 
See Chapter 2 for methods used for obtaining single fibers. 
Antibodies 
See Chapter 2 antibodies used. 
Tissue culture 
See Chapter 4 for methods used for culturing FACS sorted SCs.  See Chapter 2 for 



























CHAPTER 6: IDENTIFICATION OF CREB-DEPENDENT POLARITY 







CREB regulation of transcription has been a long-term focus of studies.  Since its original 
discovery as a transcriptional regulator of somatostatin in the nervous system (Montminy 
et al., 1986), hundreds of direct targets have been predicted for CREB and a subset have 
been validated based on gene expression levels, binding assays and sequencing analysis.  
The advent of high throughput sequencing has allowed for the discovery of non-canonical 
CREB family binding sites, in additional CREB responsive elements (CREs). ChIP-seq 
assays have determined these are actively transcribed CREB binding sites and are able to 
activate downstream targets (Martianov et al., 2010; Mayr and Montminy, 2001).  Using 
a comparative RNA-seq approach to determine genes that are directly or indirectly 
regulated by CREB along with ChIP-PCR to determine direct binding of CREB to 
conventional and novel CRE sites, I have discovered the transcriptional changes that are 







Identification of CREB downstream genes in quiescent SCs 
To ascertain the mechanism by which CREB controls SC proliferation and self-renewal, I 
identified CREB transcriptional targets in SCs. SCsA-CREB display precocious Mgn 
expression after injury/isolation, signifying early onset of defects. Therefore, to improve 
our prospects of finding primary CREB targets responsible for this effect, I harvested 
freshly isolated control and SCsA-CREB from hind limb muscles by FACS for immediately 
RNA preparation and RNA-seq. Although CREB family members are transcriptional 
activators, there was a much larger set of up-regulated (1517) than down-regulated (17) 
genes in SCsA-CREB compared to controls (Figure 22, Table 1, Table 2). A KEGG 
pathway database search (Huang et al., 2009a, 2009b) using the up-regulated gene set as 
input did not reveal pathway changes that could suggest abnormal signal transduction of 
SCsA-CREB (Table 3).  Rather, 81 up-regulated genes could be categorized into 38 KEGG 
pathways, with many of them being metabolic pathways (Table 4), which has already 
been linked to CREB function (Altarejos and Montminy, 2011).  
For identifying primary CREB targets, I focused on the 17 downregulated genes 
(Table 2). Using bioinformatics to query their promoter regions (-5kb - +1kb of the 
transcription start site), I found 16 of these genes contained at least one half-CRE and/or 
novel half-CRE site (Martianov et al., 2010); half-CRE sites have been shown to be 
highly functional in enhancing transcription of gene targets (Lesiak et al., 2013; Mayr 
and Montminy, 2001). Using the CREB database search tool (Zhang et al., 2005), 3 genes 




without a proximal TATA box (Table 2). Nr4a2 and Nr4a3 are canonical CREB target 
genes that are essential for dopaminergic differentiation and oncogenic functions, 
respectively (Ke et al., 2004; Le et al., 2003).  The remaining genes have no documented 
function in SC proliferation or self-renewal. I chose to focus on Mpp7, because it is a 
polarity protein with tangential links to both aspects of SC function in the literature.  
SCsA-CREB display altered apical protein distribution 
Mpp7, the membrane-associated guanylate kinase (MAGUK) p55 subfamily member 7, 
is a homolog to Drosophila polarity protein Stardust. It shows the highest transcriptional 
change (≥10 fold) of the down-regulated genes within SCsA-CREB (Table 2) and greatest 
transcriptional abundance among the 7 Mpp family members (Figure 23). Chromatin 
immunoprecipitation (ChIP) analysis of SC-derived myoblasts confirmed pCREB 
binding to two predicted half-CRE sites in the Mpp7 promoter (Figure 24) suggesting its 
regulation by CREB. Mpp7 has been studied in epithelial cell lines and shown to localize 
to adherens junctions and tight junctions for their maintenance (Bohl et al., 2007; Stucke 
et al., 2007). To determine Mpp7 distribution in SCs, I analyzed 3-D reconstructed 
immunofluorescence images of freshly isolated SCs on myofibers and found Mpp7 was 
preferentially localized to the apical side, opposite to β1-integrin basal localization, in the 
majority of SCs (Figure 25A-E). Consistent with Mpp7 being a target of CREB, the 
majority of SCsA-CREB displayed low to undetectable Mpp7 (Figure 25D,E).  
This prompted me to ask whether additional SC polarity proteins were affected in 
SCsA-CREB, irrespective of direct CREB regulation. M-cadherin and its intracellular 
effector β-catenin are both localized to the apical surface of SCs (Figure 26A,C,G,I). M-




CREB (Figure 26B,C). Similarly, the altered pattern of β-catenin localization followed that 
of M-cadherin (Figure 26H,I). Because SCsA-CREB are defective in proliferation, I 
examined the localization of a SC activation determinant, polarity protein Par-3. 
Unexpectedly, it was drastically reduced in SCsA-CREB, compared to its apically 
concentrated pattern in control SCs (Figure 26D-F). Conversely, distribution of the 
basally enriched β1-integrin was unperturbed in SCsA-CREB (Figure 26J-L), consistent 
with in vivo localization pattern during quiescence (Figure 7A). All together, these data 
suggest that SCsA-CREB have a partial defect in maintaining apical polarity, while retaining 







CREB activity has been implicated in myoblast proliferation (Stewart et al., 2011) 
however its role in the SC has not been determined.  Here, I found that it has a direct role 
in promoting the expression of transcript and protein of Mpp family member Mpp7, the 
membrane-associated guanylate kinase (MAGUK) p55 subfamily member 7 (Figure 23, 
24, 25). Mpp family has PDZ domains that allows for protein-protein interactions and 
categorized as a scaffolding protein (Bohl et al., 2007; Stucke et al., 2007).  Mpp7 has 
been found to be required for proper tight junction function and localized to tight and 
adherens junction (Bohl et al., 2007; Stucke et al., 2007).  Here, I found that Mpp7 
colocalizes to the apical domain as does β-catenin, an adherens junction associated 
protein (Figure 25A-E,26G-I).  Mpp7, is a homolog to Drosophila polarity protein 
Stardust of Drosophila.  Stardust is apically localized in Drosophila epithelial cells 
usually through interactions with its binding partner Crumbs (Bachmann et al., 2001).  
Interestingly, mammalian Crumbs paralogs are not expressed in SCs as assessed by 
RNA-seq of a very low FPKM (data not shown).  This provides evidence that Mpp7 does 
not coordinate with the conventional Crumbs containing Stardust complex in SCs. 
 CREB inhibition in SCs did not cause a loss in SCs (Figure 5A-C,7) however I 
found a redistribution of polarized localization of proteins (Figure 25,26). By 
immunofluorescence, Mpp7 was enriched on the apical side of quiescent SCs.  Consistent 
with the role of CREB in regulating Mpp7 expression, SCsA-CREB had reduced Mpp7 
expression.  Furthermore, M-cadherin, Par-3 and β-catenin were mislocalized of reduced 




Interestingly, Par-3 has a role in SC progenitor expansion (Troy et al., 2012) which is 









Figure 22. Flowchart followed to identify candidate CREB targets in quiescent 
satellite cells by RNA-seq (A) YFP and A-CREB satellite cells were purified by FACS 




















gene FPKM log2(fold_change) p_value 
 YFP A-CREB   
Krt8 0.0610069 5.80513 6.57221 0.000705358 
Krt18 0.117395 6.7619 5.84799 0.00208073 
Prrg4 0.420092 21.8121 5.69828 6.78448E-06 
Chrnd 0.30967 12.5592 5.34187 7.20199E-05 
Spp1 3.86619 147.259 5.2513 0.020749 
Ccnb1 0.610967 23.221 5.24819 1.41816E-05 
Chrng 0.212469 7.85277 5.20788 0.000939425 
Cdca3 0.248599 9.18565 5.20749 0.000883882 
Myh3 0.811127 24.8661 4.93811 6.19024E-07 
Pbk 0.652271 18.8544 4.85329 0.000121794 
Gm12603 0.203343 5.68829 4.80601 0.0214647 
Hist1h3c 6.15005 169.949 4.78836 7.37343E-05 
Mgst2 0.202607 5.47671 4.75656 0.0101087 
Murc 0.835802 22.4516 4.74752 6.35749E-05 
Msln 0.22054 5.85 4.72932 0.0022977 
Gmnn 0.341123 8.94634 4.71293 0.00481958 
Fgfbp1 0.419735 10.7456 4.67812 0.00201107 
Cdk1 0.67579 17.2808 4.67645 8.16873E-05 
Hist1h2ak 1.91841 48.9948 4.67465 0.0042933 
Hist1h1b 1.95106 49.7697 4.67294 0.000451499 
Hist1h2bl 3.44375 83.184 4.59425 0.00144934 
Nusap1 0.287121 6.88272 4.58325 0.0211736 
Hist1h3g 2.09432 49.6631 4.56762 0.00264656 
Top2a 2.09103 49.4078 4.56245 6.35102E-07 
Gm7325 0.538143 12.6001 4.5493 0.0120778 
Hist1h4f 14.73 340.199 4.52955 0.000188324 




gene FPKM log2(fold_change) p_value 
Ect2 0.382772 8.59593 4.4891 0.00996682 
Myog 8.63139 192.452 4.47876 5.0278E-06 
Hist1h2bb 12.9431 288.445 4.47803 0.000024766 
Hist1h2bj 7.79772 172.004 4.46324 0.000316663 
Itgb6 0.260547 5.73362 4.45983 0.0177773 
Shcbp1 0.352113 7.67954 4.44691 0.00195261 
Anln 0.716098 15.609 4.44607 9.98315E-06 
Prc1 0.988491 21.4337 4.43851 2.95164E-05 
Hist1h2bk 10.5465 225.338 4.41726 0.000148156 
Trip13 0.274261 5.72116 4.38269 0.00161692 
Psrc1 0.257311 5.3346 4.37379 0.00981444 
Spc25 0.418631 8.62798 4.36527 0.0542072 
Dusp27 0.279961 5.70974 4.35013 0.00174998 
Actc1 1.93521 39.1846 4.33972 0.000140228 
Hist1h2ab 4.05998 82.0682 4.33728 0.00103979 
Kcnn4 0.376084 7.5661 4.33042 0.0797248 
Hist1h2af 3.34683 67.2394 4.32844 0.00325721 
Hist1h2ba 0.521692 10.3284 4.30728 0.0169398 
Hist1h3b 7.54715 148.766 4.30097 0.000541508 
Kif11 0.694711 13.655 4.29687 0.000021231 
Bub1 0.298498 5.83293 4.28843 0.0024357 
Hist1h1d 0.728856 14.0345 4.2672 0.000198936 
Hist1h2bn 5.89505 113.326 4.26483 0.00101912 
Tnni1 2.0232 38.8533 4.26332 0.00104059 
Aspm 0.269771 5.04854 4.22606 2.89529E-05 
Cenpa 0.766645 14.2212 4.21334 0.0025437 
Cep55 0.323382 5.90628 4.19094 0.0328782 




gene FPKM log2(fold_change) p_value 
Hist1h1a 8.13973 147.842 4.18294 2.66167E-05 
Spag5 0.351058 6.33346 4.17321 0.000382954 
Hmmr 0.560736 10.0554 4.16451 7.12076E-05 
Hist1h3d 3.89222 68.8217 4.1442 0.00356633 
Mki67 0.631921 11.123 4.13766 5.8531E-06 
Hist1h2ag 3.94952 69.4359 4.13593 0.00247943 
Tpx2 0.390426 6.77729 4.11759 0.056262 
Uhrf1 0.898948 15.6012 4.11727 0.0310635 
Tnnc1 1.06363 18.4239 4.11451 0.00329239 
Hist1h2bg 4.49213 76.8128 4.09587 0.000822821 
Ube2c 0.303493 5.09588 4.0696 0.0341713 
Hist1h2bp 1.37799 23.1291 4.06907 0.00774465 
Igfbp2 0.660231 10.9144 4.04712 0.00432712 
Hist1h2bf 2.96651 48.878 4.04234 0.00639965 
Hist1h3i 4.18951 68.8941 4.03953 0.00196157 
Sgol2 0.356316 5.8446 4.03588 0.0271036 
Hist1h2bm 5.29126 86.5 4.03102 0.00206985 
Aif1l 2.98511 48.6471 4.0265 3.63753E-05 
Racgap1 0.636699 10.3626 4.02464 0.00172723 
2810417H13Rik 1.09323 17.7882 4.02425 0.0383771 
D2Ertd750e 0.330869 5.35009 4.01523 0.00144521 
Kbtbd5 1.29306 20.8702 4.01258 0.000261065 
Smyd1 0.312835 5.04495 4.01137 0.0170771 
Cav3 1.49574 23.9157 3.99902 0.00152257 
Hist1h2an 4.23212 67.427 3.99387 0.00538499 
Nek2 0.358574 5.69622 3.98966 0.00117659 
Ccna2 1.42767 22.5486 3.9813 0.0155669 




gene FPKM log2(fold_change) p_value 
Arpp21 0.938508 14.5758 3.95706 0.0822589 
Ttn 2.0755 32.11 3.95149 0.000765459 
Hist1h2ai 6.40865 98.9015 3.9479 0.00257753 
Hist1h2ah 4.77552 73.5864 3.94571 0.00497041 
2700094K13Rik 3.7065 56.818 3.93822 0.0246614 
Hist1h3h 5.28735 79.6643 3.91332 0.00197924 
Stac3 0.468083 7.03342 3.90939 0.00427357 
Eno3 9.11585 136.216 3.90137 0.00166074 
Hist1h4k 24.3361 361.54 3.89298 0.000411899 
Nudt14 0.882054 13.0772 3.89005 0.0173537 
H19 5.22312 76.8187 3.87847 0.000163085 
Cdc20 1.13976 16.6726 3.87068 0.0528587 
Cacng1 0.902149 13.1727 3.86804 0.00455258 
Lgals3 5.12196 74.7202 3.86673 0.0104449 
Tnnt2 0.801315 11.6273 3.85901 0.0270604 
Dut 1.14455 16.5298 3.85221 0.0178526 
Nuf2 0.714633 10.3166 3.85162 0.00137291 
Hist1h4n 20.6985 296.742 3.84161 0.000891219 
Tmem182 1.081 15.2003 3.81367 0.00634408 
Mylpf 10.7118 149.086 3.79887 0.000177689 
Trim55 0.719291 9.88994 3.78131 0.00350241 
Hist1h2ac 0.471242 6.44222 3.77302 0.00465428 
Srl 1.61045 21.9847 3.77096 0.00014586 
Itgb1bp2 0.437323 5.95466 3.76725 0.0112376 
Haus1 0.468338 6.37375 3.76652 0.0213344 
Myl4 3.66878 49.7998 3.76277 0.000563846 
Lgals1 89.7829 1216.53 3.76019 1.84622E-05 




gene FPKM log2(fold_change) p_value 
Smc2 0.969872 12.9755 3.74185 0.000125888 
Hist1h2ad 5.65152 75.313 3.73619 0.00559619 
Myof 1.57599 20.9667 3.73376 5.63823E-05 
Mcm6 2.31092 30.5999 3.72699 0.000121451 
Mcm2 0.654841 8.57903 3.7116 0.000949709 
Tsfm 1.00946 13.1915 3.70795 0.00397252 
Zwilch 0.456233 5.93805 3.70215 0.0147231 
Bex1 0.888376 11.5585 3.70164 0.0105173 
Hist1h2ae 1.56247 20.2859 3.69857 0.0104257 
Mycl1 0.402195 5.2206 3.69825 0.00245776 
Ncaph 0.611187 7.88302 3.68906 0.00107509 
Stmn1 4.19734 53.8542 3.68151 0.000341137 
Bub1b 0.84162 10.7281 3.67208 0.000391795 
1190002F15Rik 0.59415 7.54399 3.66643 0.0286886 
Plk4 0.646099 8.17909 3.66211 0.00157634 
Hist1h4b 17.9269 226.003 3.65615 0.00159054 
Hells 0.646259 7.96357 3.62323 0.00149399 
Nme4 0.56471 6.94987 3.6214 0.0178287 
Dctpp1 3.07821 37.7633 3.61682 0.00319067 
Dctn3 3.08958 37.8868 3.61621 0.0102343 
Myom2 0.576925 7.01103 3.60317 0.000479567 
Hist1h4j 17.6014 212.147 3.5913 0.00211257 
Nrcam 0.442375 5.31083 3.5856 0.00925236 
Rbm24 1.26533 15.0901 3.57601 0.000603908 
Mrpl34 0.8674 10.3379 3.57511 0.0189404 
Psmd10 1.01646 12.0981 3.57315 0.0572882 
Ccnb2 0.865692 10.3021 3.57294 0.00317641 




gene FPKM log2(fold_change) p_value 
Nudcd2 2.13504 25.2905 3.56626 0.000597026 
Gsta4 1.99721 23.6551 3.56609 0.00308834 
Casq2 0.925278 10.9524 3.56521 0.00211228 
Apool 1.14265 13.5229 3.56495 0.00698334 
Chchd10 0.530107 6.26443 3.56283 0.0287829 
Ap1s1 0.899273 10.6186 3.56169 0.00812268 
Ccng1 6.13296 72.3863 3.56106 4.45431E-05 
Ak1 1.94922 22.913 3.5552 0.0145878 
Mad2l1 0.522768 6.10649 3.5461 0.0117978 
Cdk6 0.631918 7.29922 3.52993 0.00315714 
Me2 1.21926 14 3.52134 0.000758006 
Dnajc15 4.07296 46.4516 3.51158 0.00274103 
Cdc45 0.935008 10.6463 3.50922 0.0461434 
Hist1h4i 1.75232 19.9513 3.50915 0.0185431 
Actn3 3.56459 40.2252 3.49629 0.000288917 
Rrm2 2.8386 31.8434 3.48774 0.000215263 
Ncapd2 0.869063 9.63894 3.47134 0.000663799 
Prim1 0.968265 10.7031 3.46649 0.00452179 
Nudt2 0.902328 9.90573 3.45654 0.0118296 
Pafah1b3 0.484241 5.30542 3.45367 0.0394393 
Acta1 10.6041 115.49 3.44508 0.000320268 
Dapk2 1.27262 13.8532 3.44434 0.00207483 
Dnajc9 2.82799 30.5503 3.43334 0.000457785 
Hist1h3a 7.37846 79.383 3.42744 0.00269139 
C1qtnf3 7.56952 80.7693 3.41553 0.0026738 
Hist1h2bh 3.22186 33.8774 3.39436 0.0305482 
Hist1h3e 9.52358 99.6752 3.38766 0.00483157 




gene FPKM log2(fold_change) p_value 
Prkar2b 1.18133 12.2454 3.37375 0.00110333 
Chrna1 3.0464 31.4756 3.36906 0.000278343 
Mrpl42 2.09957 21.5927 3.36238 0.00893058 
Hist1h1c 3.09472 31.6168 3.35281 0.000890371 
Tpm2 5.76486 58.6368 3.34645 0.000659327 
Hes6 2.73434 27.7661 3.34406 0.00103892 
Tmem55a 2.61027 26.4869 3.34301 0.000503576 
Areg 0.87217 8.83603 3.34072 0.00786068 
Tk1 1.32765 13.4486 3.3405 0.0174134 
Akr1b8 3.50389 35.3599 3.33508 0.00150882 
1110058L19Rik 0.759261 7.65609 3.33394 0.0365074 
C330027C09Rik 1.14529 11.5197 3.33032 0.000711035 
Galk1 1.7998 18.0023 3.32227 0.0216532 
Arl4c 1.60746 16.0589 3.32052 0.00047194 
0910001L09Rik 1.21697 12.1479 3.31934 0.0106243 
Tacc3 1.53976 15.3506 3.31751 0.000901576 
Lage3 1.36654 13.578 3.31268 0.0171489 
2410022L05Rik 0.933729 9.25029 3.30842 0.0242232 
Neb 0.95373 9.27666 3.28195 0.000959378 
Igj 0.594314 5.77177 3.27971 0.00989248 
Ccdc141 1.13137 10.9543 3.27536 0.000812113 
Fam96a 2.13378 20.5979 3.27101 0.00296089 
Kbtbd10 2.21618 21.2996 3.26468 0.00134234 
Trim72 0.829943 7.95265 3.26035 0.00417146 
D4Bwg0951e 1.02873 9.84456 3.25847 0.0077031 
Atp5k 61.0285 581.55 3.25235 0.000599814 
Mrps12 2.11835 19.908 3.23233 0.00998593 




gene FPKM log2(fold_change) p_value 
Ppil1 1.64228 15.299 3.21967 0.00628551 
Mrps16 4.64134 43.1723 3.21749 0.00538989 
1110008P14Rik 1.19606 11.0144 3.20303 0.0282628 
Hist2h3b 11.1235 102.375 3.20219 0.00462107 
Rpa3 2.25051 20.6703 3.19924 0.0172431 
Snrnp25 0.667184 6.11154 3.19538 0.0316589 
Adam19 0.633718 5.79645 3.19326 0.00152469 
Dclk1 1.94523 17.7841 3.19257 0.0598647 
Cdkn2b 0.84144 7.66335 3.18704 0.0135695 
Lrrc17 2.37897 21.6449 3.18562 0.00131897 
Nup37 1.02032 9.11376 3.15902 0.0663399 
Pdlim3 2.7805 24.8233 3.15828 0.00196301 
Hddc2 1.02945 9.15467 3.15264 0.0377383 
Eno1 10.2201 90.8806 3.15256 0.00280531 
Tead2 0.939973 8.33697 3.14883 0.0083773 
Nes 3.71339 32.8716 3.14603 0.000488737 
Smcr7 0.86569 7.60858 3.1357 0.0145176 
Bok 1.76929 15.4504 3.1264 0.00567382 
Ccdc23 2.44296 21.2824 3.12296 0.082238 
Fkbp11 0.781832 6.79886 3.12036 0.0491901 
Egln3 0.731147 6.35254 3.1191 0.00496473 
Tubg1 0.592469 5.14592 3.11862 0.0163906 
Ptgr1 1.21295 10.5294 3.11783 0.00420353 
Rnaseh2b 0.658501 5.7022 3.11426 0.0208662 
Rfc3 1.49518 12.8894 3.10778 0.00795064 
Amacr 0.607792 5.23167 3.10562 0.0117405 
Nudt8 0.608095 5.22067 3.10187 0.0488496 




gene FPKM log2(fold_change) p_value 
Pkig 3.85294 32.9161 3.09476 0.077653 
Fdps 6.51671 55.313 3.0854 0.00517903 
Mrpl22 1.98279 16.7649 3.07984 0.0129141 
Ccnd1 4.41861 37.1723 3.07256 0.000321199 
Hist1h4h 34.1516 285.958 3.06578 0.00175102 
Hmgb3 1.90477 15.8825 3.05975 0.00342075 
Hist1h2bc 11.1145 91.9067 3.04773 0.00206594 
Mgmt 1.0489 8.63358 3.04108 0.0305682 
Tnnc2 5.53723 45.3397 3.03354 0.00321645 
Tmem98 0.648072 5.30024 3.03183 0.0262774 
Dpp3 1.07833 8.80964 3.03028 0.00343722 
Mybl1 0.81628 6.63999 3.02404 0.00438392 
Serf1 0.916599 7.45046 3.02297 0.0770973 
Mrpl18 2.91918 23.6859 3.0204 0.00501231 
Nudt5 2.49416 20.2355 3.02027 0.00260948 
Ccne1 0.687196 5.54932 3.01352 0.0146047 
Cd69 0.666292 5.37687 3.01254 0.0192949 
Pnmal2 0.685093 5.51415 3.00877 0.00365086 
3110040N11Rik 0.622419 5.00896 3.00855 0.0728047 
Hist1h2be 1.34318 10.7955 3.0067 0.0834289 
Has2 1.09892 8.82473 3.00547 0.00242377 
Cib1 1.21517 9.75438 3.00489 0.0292729 
Tmem35 0.731855 5.85565 3.0002 0.0182247 
Idh2 13.7866 110.157 2.99821 0.000547276 
Jph2 0.960969 7.63258 2.98961 0.0046784 
Tmeff1 0.819822 6.4848 2.98368 0.0181103 
Hist2h2bb 42.5627 336.308 2.98212 0.00161678 




gene FPKM log2(fold_change) p_value 
Armcx6 0.719307 5.63565 2.9699 0.0137855 
Rfc5 1.00574 7.86925 2.96797 0.0102404 
Mcm5 2.94399 23.0175 2.96689 0.00138911 
Psmd5 3.73823 29.1274 2.96195 0.00211551 
Hist1h4d 51.4587 399.938 2.95829 0.00300882 
1810009A15Rik 3.82965 29.7489 2.95756 0.0113167 
Terc 4.48482 34.774 2.95489 0.0335068 
Mrpl14 1.27841 9.86159 2.94747 0.0534651 
Mrpl40 1.23219 9.49816 2.94642 0.0180325 
Adam8 1.08866 8.36119 2.94116 0.00702354 
Mfap3l 0.818986 6.27498 2.9377 0.0259372 
Anxa1 40.0269 306.028 2.93462 0.000628472 
Esrra 1.30604 9.96623 2.93185 0.0693923 
Tmsb10 85.7844 652.922 2.92812 0.00928161 
Uqcr11 35.4022 268.243 2.92163 0.00133273 
2900010M23Rik 11.2034 84.5361 2.91562 0.00434666 
Pmf1 1.29396 9.73385 2.91122 0.0223828 
Rpa1 2.60534 19.5964 2.91104 0.00244433 
Cdk4 9.20746 69.1363 2.90857 0.00150971 
Mcm3 2.49495 18.5756 2.89632 0.00227066 
Ndufb8 13.8007 102.703 2.89567 0.00213436 
Ahcy 11.4787 84.8351 2.88571 0.000510468 
Slc25a24 2.52642 18.5808 2.87864 0.00213941 
Mtap 2.16507 15.8766 2.87442 0.00338023 
Parp1 2.34011 17.1327 2.8721 0.0023247 
Cul7 1.37554 9.97924 2.85893 0.00245801 
Cks1b 4.68139 33.8724 2.8551 0.00807111 




gene FPKM log2(fold_change) p_value 
Myl1 10.8991 78.5637 2.84965 0.00922713 
Atpif1 12.0029 86.2479 2.8451 0.00500859 
Nradd 1.38188 9.92925 2.84505 0.0200585 
Med30 2.36834 17.0089 2.84434 0.0155696 
9130401M01Rik 1.6213 11.6095 2.84009 0.0145027 
S100a4 85.4526 611.347 2.8388 0.00110323 
Mcat 0.719019 5.13592 2.83652 0.0247853 
Mrpl11 1.05113 7.45409 2.82609 0.00676978 
Nfu1 1.97298 13.9879 2.82573 0.0446009 
Gamt 1.16742 8.2672 2.82407 0.0421083 
Fam83g 0.860256 6.07953 2.82112 0.00441826 
Coq9 1.62253 11.4147 2.81458 0.00852916 
Spg21 3.73883 26.2219 2.81011 0.00253978 
Rnaseh2a 0.866974 6.07412 2.80861 0.015719 
Trp53i11 0.902372 6.29013 2.8013 0.0153552 
Ass1 3.59798 25.0375 2.79883 0.00238793 
Rfc2 1.44193 10.0224 2.79717 0.0158493 
Tmem147 3.51928 24.3866 2.79274 0.0124894 
Acads 1.23546 8.53553 2.78843 0.0145392 
Slpi 1.1319 7.81891 2.78822 0.0360467 
Asns 2.0593 14.1673 2.78234 0.0096898 
Arl2 0.849033 5.84041 2.78218 0.0587651 
Pdzd11 1.1852 8.1297 2.77807 0.0276273 
Prdx2 24.5054 167.433 2.77242 0.00183671 
Sdhb 10.5298 71.9439 2.7724 0.00282304 
Sccpdh 2.49552 16.9869 2.76701 0.00559405 
Ppp1r14b 37.7857 256.9 2.7653 0.00132898 




gene FPKM log2(fold_change) p_value 
Acp1 2.91083 19.737 2.76139 0.00845341 
Suclg1 3.05889 20.7316 2.76075 0.00541395 
Hist1h4a 65.0302 439.608 2.75704 0.00473778 
Sdhd 16.146 109.058 2.75584 0.00218289 
Hist1h3f 5.03229 33.9458 2.75395 0.00966586 
N6amt2 1.62048 10.9091 2.75104 0.0424629 
Ufsp2 1.38107 9.29164 2.75015 0.0201867 
Commd3 4.73416 31.6891 2.74281 0.00696143 
Ndufv2 5.81403 38.9081 2.74246 0.00403883 
Atp5c1 23.6024 157.432 2.73772 0.00434578 
1810013D10Rik 1.71511 11.3731 2.72926 0.0295101 
2310009B15Rik 0.87617 5.80299 2.72751 0.0770067 
Mrps21 8.21687 54.3108 2.72458 0.0191469 
Coq7 1.37779 9.08033 2.72039 0.0417983 
Dtymk 5.55725 36.5696 2.7182 0.0646543 
Tpi1 21.7296 142.981 2.71809 0.00256302 
Mycbp 1.30135 8.53477 2.71334 0.0247857 
D10Jhu81e 1.89548 12.4311 2.71332 0.0149865 
Ormdl3 3.15125 20.6484 2.71203 0.00381428 
Eci1 3.02814 19.7613 2.70617 0.0081674 
Sdhc 10.801 70.4747 2.70594 0.00298625 
Tubb5 25.9198 169.088 2.70565 0.00144319 
Mrps5 3.29922 21.4742 2.70241 0.00600658 
Pmaip1 2.42773 15.801 2.70234 0.00315509 
Arhgap22 2.69561 17.5444 2.70233 0.00337646 
Jub 0.793496 5.13975 2.6954 0.0127095 
Ict1 2.26326 14.6568 2.69509 0.0276588 




gene FPKM log2(fold_change) p_value 
Ndufb3 7.79186 50.2538 2.68919 0.0125634 
Tes 1.96741 12.6826 2.68848 0.0109146 
Lmnb2 5.122 32.9799 2.68681 0.00197756 
Tufm 4.51903 29.0483 2.68437 0.021234 
Cpped1 0.802359 5.15573 2.68386 0.0203064 
Mrps33 4.23073 27.0893 2.67874 0.0601441 
4930455C21Rik 1.20241 7.69124 2.67729 0.0135986 
Ola1 5.43569 34.7162 2.67507 0.0513103 
Mrpl13 8.82534 56.2028 2.67092 0.00712413 
Pgk1 46.8011 297.959 2.6705 0.0013466 
Cops6 3.51246 22.2758 2.66492 0.0109017 
Isyna1 1.98578 12.5678 2.66195 0.0114982 
Fbxo32 1.51254 9.57161 2.66179 0.0034141 
Mrpl28 4.69631 29.5796 2.655 0.00832266 
Prdx3 5.98417 37.6859 2.6548 0.00632785 
Gart 3.12018 19.6478 2.65467 0.0034992 
Hn1l 2.89814 18.2461 2.65439 0.00563005 
Fam162a 8.87064 55.8407 2.65421 0.00734923 
Pgm2 1.55066 9.72614 2.64899 0.00742076 
Ldhb 1.36665 8.54838 2.64501 0.031357 
Ndufa9 8.12606 50.8158 2.64465 0.00470858 
Hmgn2 13.7461 85.9056 2.64373 0.00285312 
Xpo1 7.11437 44.3288 2.63944 0.0102184 
Exosc5 1.56758 9.76151 2.63857 0.0298454 
1500001M20Rik 1.16729 7.26787 2.63837 0.0349259 
Cisd1 2.81148 17.5046 2.63833 0.020841 
Ppic 9.62764 59.8745 2.63669 0.00452051 




gene FPKM log2(fold_change) p_value 
Clpp 2.12168 13.1799 2.63505 0.018566 
Ndufs8 4.64097 28.8277 2.63496 0.0116405 
Uqcr10 39.9593 248.111 2.63438 0.00404865 
Fen1 1.91137 11.8155 2.628 0.00847324 
Prkcsh 3.62889 22.2962 2.6192 0.00455956 
Atp5o 25.4937 156.545 2.61836 0.00360761 
Bin1 10.6369 65.2456 2.61681 0.0106622 
Zfand1 1.10683 6.7864 2.61622 0.0290421 
Kcnq4 1.17018 7.16997 2.61523 0.0133918 
Ndufb4 12.9872 79.5673 2.61508 0.00835863 
Popdc3 3.44945 21.133 2.61506 0.0061527 
Acta2 18.0666 110.625 2.61429 0.00613518 
Ap2s1 4.27457 26.148 2.61285 0.0156817 
Plk2 54.6685 334.188 2.61188 0.00215768 
Ano8 1.25848 7.68352 2.61009 0.0788439 
Aldh3b1 0.932016 5.68321 2.60828 0.0317848 
Commd9 0.976503 5.94763 2.60662 0.0476976 
Nans 2.66745 16.1972 2.60221 0.00880916 
Lsm7 11.8436 71.7512 2.5989 0.0116042 
Plxna1 1.91468 11.5942 2.59822 0.00354462 
Med11 1.4766 8.93579 2.59732 0.0356564 
Samm50 5.39604 32.644 2.59684 0.00644374 
Ndufc2 10.1669 61.4578 2.59571 0.0102093 
Polr2g 4.08377 24.6697 2.59477 0.0132015 
Lsm5 4.31636 26.0553 2.59369 0.0325903 
Ifngr2 1.47917 8.90735 2.59021 0.0165405 
Tmem70 3.13447 18.8733 2.59005 0.00927694 




gene FPKM log2(fold_change) p_value 
Mrpl39 1.52007 9.13865 2.58785 0.016912 
Htra2 2.2472 13.4737 2.58395 0.0653898 
Ndufc1 9.0917 54.4323 2.58184 0.0313794 
Mrps35 1.90495 11.3434 2.57403 0.0374113 
Tnni2 7.04029 41.9069 2.57348 0.0108808 
Dmpk 5.6556 33.6558 2.5731 0.0408264 
Igfbp3 3.45477 20.5294 2.57103 0.00807963 
Urod 3.79241 22.5087 2.5693 0.00924171 
Uqcrc1 10.6345 63.0488 2.56772 0.00377492 
Cmtm7 1.86456 11.0417 2.56606 0.0537777 
Adh5 6.5042 38.4865 2.56491 0.00508006 
Mrpl27 2.97184 17.5521 2.56222 0.0285934 
Mpi 1.04057 6.1446 2.56195 0.0240756 
Frmd8 1.74735 10.3113 2.56099 0.0107853 
Zfp637 1.10529 6.51629 2.55962 0.04284 
Rcc1 3.11814 18.3605 2.55784 0.0194489 
Pgam2 1.13854 6.69808 2.55656 0.0556714 
Gpx7 1.26741 7.44859 2.55508 0.0392576 
Fbxw9 1.03618 6.08539 2.55408 0.030329 
Ndufab1 2.77407 16.2646 2.55166 0.0288424 
Ociad2 1.2849 7.53238 2.55145 0.0214852 
B3gnt5 1.21868 7.13655 2.5499 0.0546907 
Phb 10.9286 63.9538 2.54892 0.00379803 
Park7 11.2452 65.7978 2.54872 0.0050108 
Myg1 1.1671 6.823 2.54748 0.0320455 
Rars2 1.01505 5.9331 2.54724 0.0329538 
Etfb 5.56315 32.5117 2.54698 0.0122427 




gene FPKM log2(fold_change) p_value 
Phlda3 6.82296 39.843 2.54586 0.00677625 
Dap 1.45607 8.48605 2.54301 0.020197 
Stoml2 4.77482 27.8251 2.54287 0.00680528 
Apeh 0.874591 5.09218 2.5416 0.0197262 
Psmb3 23.3022 135.392 2.53861 0.00459157 
Mrpl33 21.9194 127.228 2.53714 0.00659561 
Asnsd1 2.39622 13.9015 2.53641 0.00936196 
Nnt 1.23541 7.16702 2.53639 0.02521 
Usp5 4.65152 26.9712 2.53564 0.00413074 
Rab31 4.10151 23.776 2.53528 0.00602771 
Rsad2 4.06253 23.5438 2.5349 0.00832752 
Aarsd1 1.74288 10.0982 2.53455 0.0234025 
AI462493 1.1022 6.38239 2.53371 0.0607689 
Vdac1 15.26 88.1224 2.52975 0.00382331 
Psat1 15.7297 90.8263 2.52962 0.0160897 
Ndufa8 2.83485 16.3644 2.52921 0.0301162 
Ifi27l2a 4.76147 27.4727 2.52852 0.0468776 
Vim 214.735 1238.47 2.52793 0.00482379 
Ndufs5 7.74215 44.6323 2.52728 0.031299 
Dbf4 1.19286 6.86588 2.52502 0.0167149 
Lsm4 5.26897 30.268 2.5222 0.0121831 
Rnf187 4.83263 27.719 2.52 0.00642599 
Tusc3 3.18331 18.244 2.51882 0.00928254 
Cetn2 2.10595 12.0604 2.51773 0.0253279 
Smc4 5.77547 33.0678 2.51742 0.00442726 
Clybl 1.16628 6.66897 2.51555 0.0649606 
Atpaf2 1.02567 5.86092 2.51456 0.0355284 




gene FPKM log2(fold_change) p_value 
Mrpl53 4.7579 27.1256 2.51126 0.0548335 
Hist2h3c2 2.17322 12.3897 2.51123 0.0479978 
Xrcc5 2.40122 13.6885 2.51112 0.00676195 
Pkia 2.80474 15.9496 2.50759 0.00588565 
Rps27l 70.7523 401.524 2.50464 0.00420758 
Cpsf3 1.64319 9.32378 2.50442 0.0106542 
Ptcd2 1.76635 10.0088 2.50242 0.0169824 
Lars2 34.6654 196.367 2.50199 0.00242359 
Gpt2 0.94176 5.32566 2.49953 0.0147476 
Topbp1 2.70598 15.2902 2.49839 0.00551949 
Bid 0.967529 5.46626 2.49818 0.037816 
Prdx5 11.4459 64.5909 2.4965 0.00609618 
Atp5g3 43.4211 244.676 2.4944 0.00439085 
Lrwd1 1.85605 10.4551 2.4939 0.0123509 
Dcakd 1.23269 6.94015 2.49316 0.0308714 
Gipc1 1.22327 6.87353 2.4903 0.0312052 
Ndufb7 9.46544 53.1779 2.49008 0.0181536 
Fh1 6.03729 33.8915 2.48895 0.00741187 
Trappc1 1.57991 8.86531 2.48833 0.0769083 
Chchd1 10.5583 59.231 2.48798 0.0138833 
Cinp 1.70708 9.57572 2.48785 0.0378266 
Ruvbl2 6.50131 36.4537 2.48726 0.00543583 
Ptk7 1.73569 9.7317 2.48718 0.00670031 
Hibch 1.42985 8.0157 2.48697 0.0252131 
Cox6b1 58.9343 329.789 2.48436 0.00507975 
Xrcc1 1.03528 5.79244 2.48416 0.0248435 
Atp5j2 32.7863 183.44 2.48414 0.00673682 




gene FPKM log2(fold_change) p_value 
Calm3 9.65793 53.9576 2.48204 0.0056173 
Metrn 0.974552 5.44444 2.48197 0.0514142 
Mrpl47 2.89992 16.197 2.48164 0.0287604 
2010107E04Rik 84.8631 473.734 2.48087 0.00454226 
Lmo7 0.906044 5.05675 2.48056 0.0132938 
Pfn1 43.2448 241.292 2.48018 0.00511232 
Dscr3 1.89391 10.567 2.48013 0.0105518 
Ccdc56 3.60278 20.0903 2.47932 0.0303262 
Myh1 1.35071 7.52884 2.47871 0.00995452 
Cap2 2.21994 12.3152 2.47185 0.00959334 
Ndufa5 4.51242 24.9152 2.46505 0.0359941 
Psmd13 8.44441 46.5715 2.46338 0.0054453 
Adprh 1.79603 9.89389 2.46173 0.023434 
Bnip1 1.44381 7.94201 2.45963 0.0508476 
Mfn2 2.26258 12.4448 2.4595 0.00621337 
3110003A17Rik 8.65905 47.5702 2.45778 0.0126051 
Layn 1.25905 6.9082 2.45597 0.0292791 
Pdgfa 2.84508 15.6008 2.45508 0.0275262 
Ncapg2 1.57605 8.63396 2.45371 0.00642435 
Fhl2 1.371 7.50734 2.45307 0.0348748 
Ttc13 1.09649 6.00131 2.45239 0.0182033 
Psmb5 13.8487 75.7482 2.45146 0.00991047 
Prelid1 5.10478 27.9009 2.45039 0.0154503 
Vars 3.21125 17.5508 2.45033 0.00604327 
Mrps18c 6.18212 33.7874 2.45031 0.0389498 
Ndufa12 17.664 96.4865 2.44951 0.00964631 
Cox7b 22.6147 123.23 2.44602 0.00518664 




gene FPKM log2(fold_change) p_value 
Decr1 1.82469 9.9017 2.44003 0.0107773 
Tomm22 16.1873 87.7427 2.43842 0.00749307 
Rpa2 1.69499 9.15626 2.43348 0.0239906 
2310030N02Rik 1.44605 7.80174 2.43168 0.0510104 
Dynlt1a 1.8617 10.0418 2.43132 0.0610042 
Slc25a11 2.88966 15.551 2.42804 0.013295 
Tnc 8.78433 47.1899 2.42547 0.00360709 
Psmc3 24.0191 129.026 2.4254 0.00408112 
Glipr2 3.4226 18.3838 2.42527 0.0120392 
Gpc1 16.7136 89.7537 2.42495 0.0136753 
Snrpd2 44.1727 237.152 2.42458 0.00685154 
Sdf2l1 2.26065 12.126 2.42329 0.0331843 
Iffo1 2.79991 15.017 2.42314 0.0604756 
1110004E09Rik 1.01859 5.45848 2.42193 0.0582695 
Slc25a4 57.1236 305.558 2.41929 0.00399249 
2610034B18Rik 1.20291 6.4337 2.41912 0.0265936 
Ankrd32 1.06614 5.69871 2.41823 0.0149122 
Cacybp 8.86487 47.3422 2.41695 0.00701859 
Psma4 22.9432 122.413 2.41562 0.00803688 
S100a6 76.7199 409.264 2.41536 0.0057917 
Ndufa10 7.79307 41.5577 2.41485 0.00771548 
Pepd 6.22672 33.1018 2.41037 0.00721299 
Lzic 3.6957 19.6322 2.40931 0.0122289 
Rpap3 1.1059 5.86803 2.40766 0.0280649 
Mdh1 7.97933 42.2833 2.40575 0.00832929 
Tmem209 0.938024 4.96751 2.40483 0.025287 
Polr3g 0.980942 5.19417 2.40465 0.022674 




gene FPKM log2(fold_change) p_value 
Slc38a4 1.48684 7.85663 2.40166 0.0110967 
Psmg3 1.3827 7.29959 2.40032 0.0691977 
Ifit3 2.60013 13.7185 2.39947 0.0211123 
Bnip3 2.69086 14.1961 2.39936 0.0180447 
Ndufs7 6.96019 36.7134 2.39911 0.0191511 
Ndufs6 6.48909 34.2111 2.39837 0.072992 
Mex3b 1.2083 6.36926 2.39815 0.0164426 
Cbx3 10.9803 57.7246 2.39427 0.00596273 
Usp18 1.04344 5.48315 2.39366 0.0512774 
Shmt2 4.38021 23.0143 2.39346 0.0471418 
Chchd3 11.0933 58.2854 2.39344 0.0072387 
Uqcrc2 14.7059 77.2634 2.39339 0.00873767 
Phb2 13.3841 70.2724 2.39244 0.00645355 
Deb1 3.57556 18.7318 2.38924 0.0544558 
Cox5b 47.0313 245.874 2.38623 0.00716804 
Lyrm2 1.08814 5.68003 2.38404 0.0590361 
Ppip5k2 1.23111 6.42107 2.38285 0.0103695 
Mrpl45 1.42332 7.41527 2.38124 0.0220947 
Ndufb6 26.5877 137.746 2.37318 0.00976671 
3200002M19Rik 1.62846 8.42781 2.37165 0.0564414 
Sec11c 5.28766 27.3388 2.37025 0.0193494 
Idh3a 4.47044 23.1102 2.37004 0.00891096 
Dbi 18.5729 95.9471 2.36904 0.0406035 
Ndufb9 22.1362 114.353 2.36902 0.010026 
Prkaca 2.87219 14.8317 2.36846 0.0123733 
Nudt22 1.3216 6.81436 2.3663 0.0773917 
Ppap2c 1.70267 8.77035 2.36483 0.0256111 




gene FPKM log2(fold_change) p_value 
Tipin 3.73416 19.212 2.36315 0.019792 
Gfm1 3.35117 17.2339 2.36251 0.0133497 
Psma7 22.155 113.9 2.36206 0.00839072 
Asna1 3.15528 16.2185 2.3618 0.0219144 
Ndufs1 11.0345 56.6695 2.36054 0.0363311 
Fam136a 2.95759 15.1889 2.36052 0.0148829 
Tmem160 2.40755 12.3625 2.36033 0.0535449 
Cox5a 21.0428 107.991 2.35952 0.00969392 
Mrpl10 1.51828 7.78406 2.35808 0.0317777 
Hspa14 4.95317 25.383 2.35744 0.00923488 
Creld1 1.52251 7.79475 2.35605 0.0242009 
Mlf2 8.12076 41.5416 2.35487 0.0418443 
Ndufb5 11.5703 59.1657 2.35433 0.0127352 
Zfyve21 1.49066 7.61812 2.35348 0.0390453 
Naa10 6.09365 31.0964 2.35137 0.0428228 
Stbd1 1.89398 9.66408 2.35121 0.0173089 
Sae1 4.65478 23.7046 2.34838 0.0130719 
Mat2b 2.54203 12.9337 2.34708 0.0579036 
Sap30 5.26046 26.7584 2.34673 0.0141395 
Ndufs4 4.00749 20.3824 2.34655 0.0165617 
Gnpat 1.93713 9.84429 2.34537 0.0131567 
Psmb10 2.40022 12.1958 2.34515 0.0276827 
Avpi1 1.59604 8.10058 2.34353 0.0621137 
Abcb8 0.985436 4.98793 2.33961 0.0308902 
Mapk6 12.1365 61.3578 2.33789 0.0218146 
Vasp 5.19369 26.2521 2.3376 0.0144818 
Fam49b 1.92548 9.73099 2.33737 0.0121034 




gene FPKM log2(fold_change) p_value 
2400001E08Rik 1.54479 7.78535 2.33335 0.0627144 
Pts 1.50736 7.59442 2.33291 0.0688842 
Atad2 2.1769 10.9628 2.33227 0.00714785 
Gcsh 6.39815 32.1927 2.33101 0.0104961 
Mrpl21 4.25105 21.3833 2.33059 0.0211724 
Ptpla 8.69054 43.6784 2.3294 0.056747 
Tmx2 2.86803 14.3971 2.32765 0.0156388 
Mrpl3 6.34436 31.8025 2.3256 0.015209 
Gnb4 2.10462 10.5313 2.32305 0.0178784 
S1pr2 1.27509 6.37586 2.32202 0.0285087 
Tspan6 3.21904 16.0799 2.32056 0.0245915 
Cnpy2 3.14567 15.6793 2.31743 0.0363416 
Hmbs 1.00349 4.99901 2.31662 0.0787719 
Atp6v0a2 2.22276 11.0597 2.31489 0.0186609 
Wdr1 17.5484 87.3131 2.31486 0.00652637 
Ndufs3 7.67493 38.1716 2.31427 0.0172211 
Anxa2 89.6448 445.171 2.31207 0.0116863 
Cmas 2.187 10.8541 2.31122 0.0265422 
Tbca 36.5723 181.487 2.31105 0.00852655 
Hist2h2aa1 27.8692 138.188 2.30989 0.0370329 
1110059E24Rik 2.29453 11.3631 2.30808 0.0314597 
Ash2l 2.85661 14.1091 2.30425 0.0169789 
Ubac1 1.20141 5.9246 2.30199 0.0183963 
Vdac3 16.7211 82.4536 2.30191 0.029373 
Bckdk 1.07178 5.27108 2.29809 0.0367065 
Snrpe 55.9957 275.085 2.29649 0.00939246 
Mlec 4.31456 21.1747 2.29505 0.0083823 




gene FPKM log2(fold_change) p_value 
Cox7c 77.1195 377.893 2.29281 0.0080167 
Nme1 24.0069 117.214 2.28763 0.0069689 
Mrpl51 4.06831 19.854 2.28693 0.0181562 
Atox1 12.5475 61.0254 2.28201 0.0370334 
Mpdu1 2.0542 9.98836 2.28167 0.0432648 
Cops7a 3.18702 15.4949 2.28151 0.0676157 
Chmp6 1.8752 9.11194 2.28072 0.0302103 
Atp5g1 17.0904 82.9926 2.27979 0.0569471 
Nup133 2.01637 9.78014 2.2781 0.009832 
Hist1h4c 112.814 546.943 2.27744 0.0155155 
Ssna1 2.88393 13.9517 2.27433 0.0494939 
Atp5f1 26.7869 129.264 2.27072 0.0589843 
Mcm7 6.9556 33.5474 2.26995 0.0136152 
Rala 2.00372 9.64286 2.26678 0.0222295 
Hspb8 15.8291 76.0927 2.26518 0.00836654 
Pvrl2 2.6887 12.917 2.2643 0.046508 
Ccdc104 1.91718 9.19713 2.2622 0.0285092 
Plin3 3.77832 18.0948 2.25976 0.0132183 
Dll1 3.13445 15.0066 2.25932 0.0165271 
Cyc1 11.1789 53.5191 2.25928 0.0149345 
Tmem63b 1.33953 6.41267 2.2592 0.0201461 
Tbcd 2.81659 13.4825 2.25907 0.0255387 
Dnmt1 3.09621 14.8007 2.25709 0.0421779 
Mtx2 3.28758 15.7094 2.25653 0.0335635 
Dnpep 2.73045 13.0434 2.25611 0.0376731 
Efha1 3.00305 14.345 2.25605 0.0190442 
Cmpk2 1.34184 6.4058 2.25516 0.0278174 




gene FPKM log2(fold_change) p_value 
Lias 1.31211 6.25694 2.25357 0.0455409 
Tomm5 18.8372 89.8064 2.25323 0.0506988 
Prpf31 2.43624 11.6138 2.25311 0.0547039 
Ankrd1 13.0208 62.0266 2.25207 0.00859573 
Crip2 8.48826 40.4339 2.25202 0.0149443 
Anapc4 3.84936 18.3338 2.25182 0.0133058 
Setd8 3.31395 15.7784 2.25133 0.0194114 
Tmem38a 2.01789 9.60106 2.25035 0.0253052 
Psmc1 13.4496 63.925 2.24882 0.0110734 
Polr2e 6.18854 29.4046 2.24837 0.0211194 
Fbxl19 1.04614 4.96962 2.24806 0.0283601 
Snrnp27 3.57504 16.9692 2.24689 0.0409478 
H1f0 1.70315 8.07711 2.24563 0.0326096 
Ndufaf2 2.38593 11.3068 2.24456 0.0682632 
Atp5g2 29.8823 141.422 2.24265 0.0145032 
March8 3.32018 15.705 2.24189 0.0120623 
Cdc123 3.41193 16.1282 2.24093 0.0216967 
Vamp8 3.97986 18.8009 2.24001 0.0403227 
Sox11 1.47082 6.94279 2.23889 0.0128834 
Mrpl36 2.66441 12.5663 2.23766 0.0582679 
Nedd8 12.733 59.9996 2.23639 0.0177565 
Mrpl9 8.08195 38.0769 2.23614 0.0137008 
Taldo1 16.0276 75.5085 2.23608 0.0108119 
Bod1 6.59 31.0418 2.23586 0.0162726 
5730437N04Rik 6.42561 30.203 2.23279 0.020246 
Uqcrfs1 13.9384 65.5065 2.23257 0.0128744 
Pebp1 34.5223 162.089 2.23118 0.00843761 




gene FPKM log2(fold_change) p_value 
Dnajc2 3.19625 14.9862 2.22918 0.0132916 
Mrps27 1.86295 8.72895 2.22822 0.0481874 
Zfp367 3.46121 16.2144 2.22793 0.0102234 
Arl6ip1 7.0157 32.856 2.2275 0.0133861 
Aifm1 1.16239 5.44065 2.22668 0.037949 
Nit2 1.79867 8.40911 2.22503 0.0476405 
Atic 5.54284 25.9092 2.22477 0.0130955 
2810004N23Rik 2.72521 12.7348 2.22434 0.0278652 
Taf12 1.9887 9.28758 2.22348 0.0543414 
Pfdn1 5.81574 27.1499 2.22291 0.0210851 
Trappc2l 3.0921 14.4233 2.22174 0.0718674 
Prmt5 1.98112 9.22427 2.21912 0.0205911 
Fam111a 2.13271 9.92061 2.21774 0.0195029 
Ccdc134 3.44177 16.0066 2.21745 0.0159728 
Vdac2 20.7207 96.305 2.21654 0.011736 
Nono 19.7148 91.6077 2.21619 0.0243929 
Fzr1 1.18955 5.52409 2.21532 0.039204 
Mre11a 1.34885 6.26101 2.21466 0.0265973 
Dhrs1 2.2443 10.4164 2.21452 0.0390195 
Cox7a2 38.8248 179.941 2.21247 0.0107292 
Myzap 1.32905 6.15819 2.21211 0.0398943 
Smarcc1 1.98565 9.18938 2.21035 0.0123241 
Psmb2 15.6259 72.3024 2.2101 0.0196889 
Exosc9 5.32826 24.6431 2.20945 0.0432177 
Nipsnap3b 1.82728 8.44627 2.20862 0.048784 
Il33 7.83594 36.2069 2.20808 0.0592863 
Atp2a1 4.39552 20.3068 2.20786 0.0299324 




gene FPKM log2(fold_change) p_value 
Hmgb1 39.5937 182.536 2.20484 0.00732762 
Cpsf3l 1.94288 8.95564 2.2046 0.0625531 
Fkbp4 13.1049 60.4 2.20445 0.00967832 
Polr2f 8.51876 39.2244 2.20303 0.0424886 
Cops5 6.28979 28.9554 2.20275 0.0179292 
Pycr2 4.51294 20.775 2.20271 0.0171067 
Lap3 5.81449 26.7631 2.20252 0.0159745 
2810405K02Rik 2.69824 12.4013 2.2004 0.0693638 
Gins4 1.67622 7.69072 2.19791 0.0536535 
Tmem14c 6.01911 27.6091 2.19752 0.0223595 
Polr2i 3.08796 14.1421 2.19527 0.0683858 
Timm13 4.57269 20.9196 2.19374 0.030617 
Ppa2 1.7624 8.06126 2.19346 0.0619436 
Bax 10.1894 46.5523 2.19178 0.0213076 
Tceal8 3.80299 17.373 2.19165 0.0500367 
Acadl 4.94377 22.5589 2.19001 0.018281 
Alg5 1.66498 7.59591 2.18972 0.0465145 
Tsta3 1.75515 8.00661 2.1896 0.0465645 
Snap47 1.831 8.35208 2.1895 0.0331034 
Col18a1 4.80413 21.9136 2.18948 0.0842557 
Mrpl37 1.49583 6.81942 2.1887 0.0611183 
Ppp1ca 26.47 120.55 2.1872 0.0167651 
Got1 2.99766 13.6313 2.18501 0.0294386 
Slc35a1 2.02406 9.20266 2.1848 0.0316693 
Mdh2 21.6036 98.1796 2.18415 0.0122389 
Ttc33 2.12881 9.67155 2.1837 0.0310839 
Cdk5rap3 1.42067 6.45397 2.18362 0.0376709 




gene FPKM log2(fold_change) p_value 
Ints4 1.91807 8.70732 2.18257 0.0228018 
Gfod1 2.81368 12.7649 2.18165 0.0134448 
Ccdc8 1.10238 5.00067 2.18149 0.0406064 
Hist2h2ac 22.0473 99.9454 2.18054 0.0342955 
Elof1 3.87324 17.5551 2.18028 0.0334311 
Myeov2 19.5656 88.5714 2.17852 0.0582137 
Ndufb10 13.1347 59.4119 2.17736 0.020052 
Immt 6.23689 28.205 2.17705 0.0668266 
Atp5e 79.7158 360.495 2.17704 0.0116875 
Psmg1 3.36238 15.1966 2.1762 0.0365003 
Cks2 8.77196 39.6416 2.17605 0.025857 
Psmd6 16.3531 73.8261 2.17457 0.0138394 
Naa38 4.60002 20.7658 2.1745 0.0452354 
Uba3 11.0446 49.8469 2.17416 0.0460641 
Cyld 2.07861 9.37942 2.17388 0.0760655 
Ostc 8.14916 36.767 2.17369 0.0220255 
Ppa1 14.7997 66.7414 2.17301 0.012684 
Ndufa7 19.2436 86.7283 2.17212 0.0225473 
Qdpr 1.3733 6.18608 2.17138 0.0558031 
Apoa1bp 4.96312 22.3347 2.16997 0.0364552 
Pgls 4.57636 20.5925 2.16984 0.0454154 
Foxred1 2.46354 11.0741 2.16839 0.0187405 
Spc24 3.06852 13.7933 2.16835 0.0246364 
Eif2b5 6.7319 30.1788 2.16445 0.0137287 
2310016M24Rik 4.60266 20.6125 2.16298 0.0520383 
Ppia 421.189 1883.54 2.16091 0.0102246 
Ssu72 4.01914 17.9689 2.16054 0.0235571 




gene FPKM log2(fold_change) p_value 
6330578E17Rik 1.77391 7.9131 2.15731 0.024179 
Gtf2h2 1.46666 6.52897 2.15432 0.0453213 
Cdc26 3.32639 14.7937 2.15295 0.0540202 
Tmem132a 2.38406 10.6007 2.15267 0.0249269 
Afg3l1 1.16944 5.19928 2.15249 0.0805996 
Cars2 1.13545 5.03028 2.14737 0.0597979 
Mrpl44 1.74906 7.74261 2.14624 0.0551484 
Mustn1 2.04932 9.06932 2.14585 0.0648217 
Commd1 10.3967 45.9776 2.1448 0.0639147 
Prim2 1.94639 8.60752 2.14479 0.0364799 
Dgkz 2.22822 9.85173 2.14448 0.0643848 
Slc44a2 3.45645 15.2748 2.14379 0.0398007 
Nup93 3.22256 14.2405 2.14372 0.0170013 
Prep 4.27117 18.8658 2.14307 0.019856 
Polr2k 11.4815 50.6964 2.14257 0.0607946 
Psmb1 32.9609 145.538 2.14257 0.010874 
Iqsec3 1.97756 8.71759 2.14021 0.0165314 
Cog4 2.8174 12.403 2.13825 0.0196465 
AI314976 1.52097 6.69245 2.13754 0.0667552 
Exoc7 1.46071 6.42545 2.13713 0.0534254 
Ublcp1 2.63554 11.5855 2.13615 0.026975 
Ric8 3.0436 13.3524 2.13325 0.030623 
Aimp1 7.30475 32.0204 2.13208 0.0228961 
Cstf2 2.70492 11.8402 2.13004 0.0253991 
Abhd8 1.38153 6.0304 2.12598 0.0496794 
Suds3 4.40149 19.2037 2.12532 0.050484 
Rpp30 2.8432 12.3919 2.12381 0.0474875 




gene FPKM log2(fold_change) p_value 
Rcn1 6.93806 30.2057 2.12222 0.0152107 
Pomp 21.2409 92.4582 2.12196 0.0194203 
Cnn2 2.87584 12.5143 2.12153 0.0374232 
0610037P05Rik 3.26532 14.1986 2.12045 0.0389912 
Psmd14 14.6692 63.7305 2.11919 0.0138016 
H2afj 2.17157 9.42359 2.11754 0.0391565 
Psma5 23.307 101.02 2.1158 0.0129325 
Got2 6.66198 28.8485 2.11447 0.0212769 
Tsc22d1 12.061 52.2155 2.11413 0.0519005 
Rab1b 6.23002 26.9686 2.11397 0.0249934 
Acat1 4.5574 19.727 2.11389 0.0157703 
Thop1 4.46625 19.3228 2.11317 0.02056 
Ubr7 1.96641 8.50704 2.1131 0.026139 
Coro1c 5.62478 24.3316 2.11296 0.0183737 
Prkag1 4.88335 21.1238 2.11293 0.0271953 
Stambpl1 1.50917 6.52806 2.1129 0.0438251 
Sfxn1 1.49534 6.45698 2.11039 0.0338328 
Pkm2 131.407 567.266 2.10998 0.0110944 
Ino80c 2.08279 8.97899 2.10804 0.0364011 
Nae1 4.24419 18.2901 2.1075 0.0280328 
4930503L19Rik 1.31233 5.65441 2.10725 0.0523444 
Atp6v1c1 3.85755 16.6187 2.10705 0.0298769 
Mrps11 2.18407 9.40871 2.10698 0.0711246 
Fitm1 2.39912 10.3274 2.1059 0.0782815 
Ywhah 7.79244 33.4405 2.10145 0.0237238 
Atp5a1 81.6715 350.418 2.10117 0.0113529 
Idh1 3.28772 14.1018 2.10071 0.0819549 




gene FPKM log2(fold_change) p_value 
Cs 11.2988 48.4048 2.09898 0.0145637 
Olfml2b 12.0383 51.5336 2.09788 0.0129886 
Polr2j 9.05317 38.7244 2.09675 0.0384325 
Clns1a 2.21882 9.48067 2.09519 0.0250517 
Psma6 22.8882 97.7881 2.09506 0.0178766 
Edf1 11.5364 49.2648 2.09436 0.0321384 
Sesn3 2.04728 8.74201 2.09426 0.0334709 
Xrcc6 1.91585 8.17079 2.09249 0.0357749 
Mrps24 3.7853 16.1098 2.08946 0.0441471 
Plekho1 1.60027 6.80648 2.08859 0.0803215 
Exosc4 1.78208 7.57855 2.08836 0.0446844 
Tssc1 1.55403 6.60366 2.08726 0.0555556 
Poldip2 4.94137 20.9797 2.08601 0.0256769 
Pgam1 21.8802 92.8809 2.08575 0.0132425 
Pdia4 15.4557 65.5361 2.08415 0.0176883 
Elp2 3.72826 15.7739 2.08097 0.0227772 
Mif 32.1395 135.928 2.08042 0.0251438 
Traf3ip3 1.27456 5.38919 2.08007 0.0752786 
Ammecr1 1.20692 5.1008 2.07939 0.0454845 
1110002B05Rik 5.60369 23.6458 2.07714 0.0302021 
Tmem199 2.29663 9.69077 2.07709 0.0477981 
Prpf19 4.54875 19.1898 2.0768 0.0776143 
Ccdc72 16.9511 71.5087 2.07674 0.0235969 
Med21 7.04011 29.6334 2.07356 0.0364509 
Hadh 2.63042 11.0703 2.07332 0.031292 
Ap1b1 2.19633 9.24111 2.07297 0.0706386 
C1d 2.0338 8.54813 2.07143 0.0306263 




gene FPKM log2(fold_change) p_value 
Mtch2 7.13812 29.977 2.07024 0.0244968 
Scd2 5.67748 23.8027 2.0678 0.0206144 
Ahsa1 21.0018 88.0411 2.06766 0.0167624 
Nup43 1.78336 7.47354 2.0672 0.0727777 
1810006K21Rik 14.8539 62.2001 2.06607 0.0759236 
Sf3b5 5.75508 24.0815 2.06502 0.05339 
Il13ra1 1.70626 7.13523 2.06412 0.0355183 
Ppib 43.5194 181.909 2.06349 0.0426019 
Tsen15 2.26794 9.47678 2.06301 0.064412 
Ckb 8.38623 35.0178 2.06199 0.0275515 
Sft2d2 1.67182 6.98057 2.06193 0.0232308 
2810474O19Rik 5.12524 21.3854 2.06093 0.013389 
Larp7 7.01877 29.145 2.05395 0.0244938 
Paics 19.7448 81.9839 2.05387 0.0426938 
Cad 2.34016 9.70114 2.05155 0.0197299 
Npm3 15.1954 62.9649 2.05092 0.0236262 
Serpinh1 79.3591 328.203 2.04812 0.0305215 
Pmpcb 14.9461 61.7897 2.04759 0.0172757 
Commd8 1.57394 6.50599 2.04739 0.032543 
Spg7 2.8785 11.895 2.04697 0.0265695 
Ddx1 13.2988 54.927 2.04622 0.0153345 
Psmb6 33.4566 138.031 2.04463 0.0176963 
Lrpprc 5.50567 22.6956 2.04343 0.0178768 
Ei24 2.66202 10.961 2.04179 0.0795095 
Traf4 1.73238 7.12695 2.04053 0.0356303 
Mrps22 3.67222 15.0995 2.03977 0.0449608 
Pdcd5 8.9898 36.8625 2.03579 0.0455262 




gene FPKM log2(fold_change) p_value 
Atp6v1e1 8.13399 33.2207 2.03005 0.0327898 
Pop4 6.21974 25.3778 2.02864 0.030523 
Rtn2 9.06006 36.9602 2.02838 0.0855513 
Eif4ebp1 10.2523 41.8039 2.02768 0.0313278 
Vps36 5.13257 20.9213 2.02722 0.03168 
Ncoa7 3.80846 15.5227 2.0271 0.0594533 
Rapsn 5.51555 22.4743 2.0267 0.0309586 
Mrpl54 8.92394 36.3557 2.02643 0.0490171 
Pycrl 2.50286 10.189 2.02536 0.0530109 
Mfsd11 1.61768 6.5823 2.02467 0.0419593 
Kifap3 1.3067 5.31659 2.02458 0.0327427 
Fech 1.68998 6.86836 2.02296 0.0397171 
Leprot 4.10523 16.6825 2.0228 0.0358369 
Cog6 1.4389 5.846 2.02248 0.0501074 
Cdk2ap1 13.5323 54.9145 2.02078 0.0233438 
Aco2 18.3301 74.3606 2.02032 0.0238699 
Isca2 2.28878 9.27875 2.01935 0.0824718 
Khdrbs3 3.47796 14.0958 2.01895 0.0359199 
Nudt21 14.4232 58.3905 2.01734 0.0264913 
Stard7 7.12129 28.8226 2.01699 0.019754 
Pld3 1.94477 7.86624 2.01608 0.0462395 
Mipep 1.51209 6.1148 2.01576 0.0798602 
Ccdc12 4.35944 17.629 2.01574 0.0466375 
Adsl 5.35176 21.6058 2.01333 0.0253845 
Rbfa 1.5647 6.30859 2.01143 0.0770641 
Psma2 33.4715 134.861 2.01047 0.0189148 
Swi5 24.1017 97.0983 2.01031 0.0211282 




gene FPKM log2(fold_change) p_value 
Cd83 2.27188 9.13687 2.00781 0.0348761 
Stard3nl 2.26265 9.09728 2.00742 0.0827412 
Mrps28 7.88982 31.7136 2.00704 0.0415904 
BC003965 2.06635 8.30477 2.00686 0.040174 
Krcc1 2.64446 10.6182 2.0055 0.0384308 
Mrpl20 13.3267 53.506 2.00538 0.0330346 
Ttc9c 2.02004 8.1074 2.00485 0.0318204 
Gga2 1.27356 5.11034 2.00455 0.0343175 
Fbxl6 1.51054 6.05874 2.00395 0.0780474 
Isoc1 2.19961 8.81487 2.00269 0.0422024 
5430437P03Rik 2.32643 9.32204 2.00253 0.0477616 
Hint2 5.51041 22.0662 2.00161 0.0790645 
Dnaja3 3.26623 13.0726 2.00085 0.0804597 
Actn1 4.3106 17.246 2.0003 0.024846 
Ankrd10 17.9497 71.7932 1.99989 0.0614615 
Cox8a 42.7339 170.887 1.99959 0.0282898 
Rp9 3.53385 14.1287 1.99931 0.0445406 
Mrps31 2.01487 8.05352 1.99893 0.0580432 
Ppie 5.27312 21.0743 1.99875 0.0370228 
Bloc1s2 3.0401 12.1261 1.99592 0.0619456 
Alkbh3 2.26594 9.03709 1.99575 0.0719086 
Snrpg 65.9579 262.966 1.99526 0.0292972 
Arpc5l 3.40297 13.5671 1.99525 0.047297 
Glrx5 5.68695 22.6688 1.99498 0.0469276 
Tuba1b 57.9886 231.041 1.99431 0.01603 
Kdelc1 1.43959 5.73392 1.99386 0.0550283 
Me1 1.98414 7.90226 1.99375 0.0787404 




gene FPKM log2(fold_change) p_value 
Cd320 1.29165 5.13869 1.99219 0.0726578 
Pop5 3.00561 11.9542 1.99179 0.0811028 
Naa20 8.50461 33.8201 1.99156 0.084593 
Psma1 19.0929 75.8942 1.99095 0.021742 
Fam60a 3.45185 13.7194 1.99077 0.0288984 
Ssrp1 11.6735 46.3782 1.99021 0.049988 
Sc4mol 6.60402 26.2214 1.98933 0.0340125 
Tomm7 14.4321 57.2482 1.98795 0.0282363 
Atp5b 161.547 639.993 1.9861 0.0326041 
Ptges2 2.01538 7.97966 1.98528 0.0551061 
Sgcb 2.25039 8.88597 1.98135 0.0294194 
St13 16.2301 64.0769 1.98114 0.0241345 
Mrpl12 6.13649 24.2198 1.9807 0.0399968 
Gm13253 5.15202 20.3317 1.98052 0.0595096 
Acaa2 5.19071 20.4701 1.97951 0.0343733 
Cnot8 3.56861 14.062 1.97836 0.0397652 
Nxn 3.32536 13.1014 1.97814 0.0334449 
Dhrsx 2.47822 9.75337 1.9766 0.0548158 
Cnih4 1.90787 7.50709 1.97629 0.0459443 
Cox6c 58.2749 229.279 1.97615 0.0234871 
Coro1a 1.82934 7.19647 1.97596 0.0575286 
Mrpl2 2.88851 11.3561 1.97507 0.0668606 
Tbcb 5.42958 21.3386 1.97455 0.0403471 
Esd 43.6044 171.341 1.97432 0.0200908 
Sepw1 14.983 58.8131 1.97281 0.039074 
Actl6a 6.04327 23.6995 1.97146 0.0305098 
Maged2 4.72377 18.5214 1.97118 0.0851931 




gene FPKM log2(fold_change) p_value 
Hspd1 74.8671 293.323 1.97009 0.0176661 
2700060E02Rik 12.7152 49.748 1.96809 0.0778517 
Il1b 3.91798 15.3129 1.96656 0.0405945 
Dyrk2 2.84398 11.1139 1.96639 0.0401744 
Fabp5 7.0951 27.7236 1.96622 0.0485113 
Acadm 5.48991 21.4275 1.96461 0.0331042 
Snx1 15.0187 58.5855 1.96379 0.0206294 
Abcb7 1.87494 7.31184 1.96339 0.0280373 
Wbp5 28.5041 111.141 1.96314 0.0220936 
Atp5l 99.2072 386.491 1.96192 0.0219131 
Rchy1 2.60983 10.1596 1.96081 0.0602996 
Atp6v1d 2.94029 11.439 1.95993 0.0604716 
Psph 2.58901 10.0665 1.95909 0.0561099 
Cfdp1 11.6565 45.2532 1.95688 0.031039 
Txndc17 5.54738 21.53 1.95647 0.0440206 
Cops4 11.326 43.9039 1.95471 0.0273674 
Uxs1 6.17027 23.9103 1.95422 0.0339157 
Vps37b 2.79149 10.807 1.95285 0.0488482 
Cbx1 2.97166 11.4923 1.95132 0.0702127 
Sec61b 17.6264 68.0608 1.94908 0.0462842 
Ppm1f 2.12752 8.20825 1.9479 0.0376923 
Mff 4.37802 16.8789 1.94687 0.0349855 
Rassf8 2.21305 8.52027 1.94487 0.0444261 
Angptl2 4.60446 17.7159 1.94395 0.0429214 
Trap1 6.2835 24.1667 1.94338 0.0373125 
Asl 1.61848 6.21823 1.94186 0.0706307 
Maea 8.00655 30.7451 1.94111 0.0305452 




gene FPKM log2(fold_change) p_value 
Cyb5r1 3.48358 13.3701 1.94037 0.0467742 
Pdcl3 3.46907 13.2852 1.9372 0.0505475 
Bcas2 6.96026 26.6167 1.93512 0.0313753 
Lsm3 11.6869 44.6714 1.93446 0.0467887 
Ktn1 6.73862 25.7464 1.93384 0.0226934 
Impa1 2.15237 8.2192 1.93307 0.0474848 
Spr 4.52732 17.2765 1.93208 0.0516467 
Gtf3c3 1.52656 5.82182 1.93119 0.0534947 
Tmem126a 6.43392 24.5134 1.9298 0.0606313 
Akr1a1 19.4276 74.0082 1.92958 0.0278299 
Fam18b 2.75446 10.4835 1.92829 0.0507673 
Smarcd3 2.65373 10.0979 1.92796 0.0517689 
Lta4h 4.67594 17.7422 1.92386 0.0356365 
Wdr18 2.79888 10.6186 1.92368 0.0391079 
Mrpl16 3.51909 13.3398 1.92247 0.0606759 
Etfdh 4.48806 17.0095 1.92218 0.0378123 
Armc1 2.91686 11.0534 1.922 0.0363485 
Lgmn 5.25042 19.8745 1.92042 0.0413793 
 
















CREB tgacg cgtca tggcg 
Mpp7 54.35 4.99 -3.44 0.0041 +   +++ unknown 
Alpl 7.85 1.04 -2.91 0.0018   + ++ no 
Slc10a6 31.33 5.05 -2.63 0.0017 ++   ++ no 
Slc15a2 8.12 1.37 -2.57 0.0070 ++ +++ ++ no 
Sele 4.88 1.04 -2.23 0.0302 + + + no 
Nr4a3 9.01 1.99 -2.18 0.0174 + + ++ no 
Timp4 8.80 2.09 -2.07 0.0678       no 
Mpz 10.59 2.64 -2.01 0.0555 +++   + no 
Eltd1 4.96 1.36 -1.87 0.0622   ++ + 
CRE_NoTAT
A 
Chrdl2 5.19 1.48 -1.81 0.0651 + + ++++ no 
Nr4a2 5.68 1.68 -1.76 0.0854 ++++ ++++ +++++ CRE_TATA 
Esm1 9.88 2.98 -1.73 0.0778 +++++ + + CRE_TATA 
Akap12 8.68 2.71 -1.68 0.0656   +++   no 
Apold1 9.52 3.09 -1.62 0.0852 +++   ++ CRE_TATA 
Alpk1 5.45 1.82 -1.58 0.0578     + no 
Map3k6 23.20 8.13 -1.51 0.0650 + + ++++++ no 
Tnfaip6 
126.0
7 47.13 -1.42 0.0696 +     no 
	 	 	 	 	 	 	 	 	+ indicates one respective site 
	 	 	 	 	 	 	 	 	Table 2. Genes significantly differentially down-regulated in SCsA-CREB compared 








































































































































































































































	 	 	 	
Wnt16	 0.06	 0.07	




	 	 	 	
Wnt2	 0.05	 0.02	




	 	 	 	
Wnt2b	 0.25	 0.24	




	 	 	 	
Wnt3	 0.06	 0.04	
	 	 	 	 	 	 	 	 	
Grb2	 7.56	 15.56	
	 	 	 	
Wnt3a	 0.05	 0.01	
	 	 	 	 	 	 	 	 	
Sos1	 3.14	 4.91	
	 	 	 	
Wnt4	 1.46	 1.76	
	 	 	 	 	 	 	 	 	
Sos2	 5.17	 8.43	
	 	 	 	
Wnt5a	 0.15	 0.30	
	 	 	 	 	 	 	 	 	 	
FPKM	
	 	 	 	
Wnt5b	 0.22	 0.39	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Wnt6	 0.33	 0.39	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Wnt7a	 0.04	 0.00	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Wnt7b	 0.11	 0.91	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Wnt8a	 0.06	 0.05	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Wnt8b	 0.06	 0.03	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Wnt9a	 0.36	 0.95	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
	
FPKM	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
low	 		 high	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
3	 20	 150	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
*no	differences	in	FPKM	between	YFP	and	A-CREB	expressing	cells	were	significant	by	cuffdiff	analysis	
	 	 	 	 	 	 	 	 	
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	







Term Genes p_value FDR 
mmu05016:Huntington's 
disease 
UQCRC2, ATP5E, UQCRC1, AP2S1, ATP5B, 
CYC1, NDUFAB1, UQCRFS1, COX5A, 
COX5B, NDUFS7, GPX1, NDUFS6, NDUFS5, 
CASP3, UQCR10, UQCR11, NDUFS4, 
NDUFS8, ATP5O, NDUFS3, NDUFS2, ATP5H, 
NDUFS1, NDUFB10, SLC25A4, CYCS, 
NDUFC2, COX4I1, NDUFC1, NDUFA10, 
COX6C, DCTN2, UQCRH, ATP5C1, UQCRB, 
NDUFB3, POLR2H, NDUFB4, POLR2G, 
POLR2F, NDUFB5, NDUFB6, POLR2E, 
NDUFB7, NDUFB8, POLR2K, NDUFB9, 
POLR2J, POLR2I, COX7B, COX7C, ATP5G2, 
ATP5G1, ATP5G3, POLR2C, NDUFB2, 
COX6B1, NDUFA4, NDUFA5, NDUFA2, 
COX7A2, NDUFA8, NDUFA9, NDUFA6, 
COX8A, NDUFA7, ATP5F1, VDAC2, VDAC3, 
NDUFA1, VDAC1, SDHA, SDHB, HDAC2, 






Term Genes p_value FDR 
mmu00190:Oxidative 
phosphorylation 
UQCRC2, ATP5E, UQCRC1, ATP5B, CYC1, 
NDUFAB1, UQCRFS1, COX5A, COX5B, 
NDUFS7, NDUFS6, NDUFS5, UQCR10, 
UQCR11, NDUFS4, NDUFS8, ATP5L, ATP5O, 
NDUFS3, NDUFS2, ATP5H, COX17, NDUFS1, 
ATP5K, NDUFB10, NDUFC2, COX4I1, 
NDUFC1, NDUFA10, ATP6V1D, COX6C, 
ATP6V1C1, ATP6V1A, UQCRH, ATP5C1, 
UQCRB, NDUFB3, NDUFB4, NDUFB5, 
NDUFB6, NDUFB7, NDUFB8, NDUFB9, 
COX7B, COX7C, ATP5G2, ATP6V1B2, 
ATP5G1, ATP6V1G1, ATP5G3, NDUFB2, 
COX6B1, NDUFA4, NDUFA5, NDUFA2, 
ATP5J2, COX7A2, NDUFA8, NDUFA9, 
NDUFA6, NDUFA7, COX8A, ATP5F1, 
NDUFA1, PPA2, PPA1, SDHA, SDHB, 
NDUFV1, ATP6V1E1, SDHC, NDUFV2, 





Term Genes p_value FDR 
mmu05010:Alzheimer's 
disease 
UQCRC2, ATP5E, UQCRC1, ATP5B, IDE, 
CYC1, NDUFAB1, UQCRFS1, COX5A, 
COX5B, NDUFS7, NDUFS6, NDUFS5, CASP3, 
UQCR10, UQCR11, NDUFS4, NDUFS8, IL1B, 
ATP5O, NDUFS3, NDUFS2, ATP5H, NDUFS1, 
NDUFB10, CYCS, NDUFC2, COX4I1, 
NDUFC1, NDUFA10, COX6C, UQCRH, 
ATP5C1, GM12070, UQCRB, NDUFB3, BID, 
NDUFB4, NDUFB5, NDUFB6, NDUFB7, 
NDUFB8, NDUFB9, COX7B, COX7C, 
ATP5G2, ATP5G1, ATP5G3, NDUFB2, 
COX6B1, GAPDH, NDUFA4, NDUFA5, 
NDUFA2, COX7A2, NDUFA8, NDUFA9, 
NDUFA6, NDUFA7, COX8A, ATP5F1, CAPN2, 
NDUFA1, NAE1, SDHA, SDHB, NDUFV1, 






Term Genes p_value FDR 
mmu05012:Parkinson's 
disease 
UQCRC2, ATP5E, UQCRC1, ATP5B, CYC1, 
NDUFAB1, UQCRFS1, COX5A, COX5B, 
NDUFS7, NDUFS6, NDUFS5, UQCR10, 
CASP3, UQCR11, NDUFS4, HTRA2, NDUFS8, 
ATP5O, NDUFS3, ATP5H, NDUFS2, NDUFS1, 
NDUFB10, SLC25A4, CYCS, NDUFC2, 
COX4I1, NDUFC1, NDUFA10, COX6C, 
UQCRH, ATP5C1, UQCRB, NDUFB3, 
NDUFB4, NDUFB5, NDUFB6, NDUFB7, 
NDUFB8, NDUFB9, COX7B, COX7C, 
ATP5G2, ATP5G1, ATP5G3, NDUFB2, 
COX6B1, NDUFA4, NDUFA5, NDUFA2, 
COX7A2, NDUFA8, NDUFA9, NDUFA6, 
NDUFA7, COX8A, ATP5F1, VDAC2, VDAC3, 
NDUFA1, PARK7, VDAC1, SDHA, SDHB, 
NDUFV1, SDHC, NDUFV2, SDHD, ATP5A1 
5.20E-35 6.31E-32 
mmu04110:Cell cycle 
FZR1, DBF4, CDC16, SKP1A, RBX1, CCNE1, 
CDC45, MCM7, CDKN2B, BUB1, CCNA2, 
BUB3, TFDP1, ANAPC1, CDK1, ANAPC4, 
CDK6, CDC20, MCM2, CDC26, CDK4, MCM3, 
MCM4, MCM5, MCM6, CCNB1, CCND1, 






Term Genes p_value FDR 
mmu03040:Spliceosome 
NCBP1, CCDC12, 0610009D07RIK, PPIL1, 
CWC15, LSM7, SNRPD1, SNRPD2, SF3B5, 
NAA38, SF3B2, CTNNBL1, PRPF19, LSM5, 
LSM4, LSM3, BCAS2, SNRPA1, PRPF31, 
EFTUD2, PRPF6, SF3A3, PPIE, SNRNP200, 





POLR2H, POLR2G, POLR2F, POLR2E, 
POLR2K, POLR2J, POLR2I, PNPT1, POLA1, 
POLR2C, PRIM1, ATIC, POLE3, PRIM2, 
PAPSS1, POLR3G, NUDT2, AK1, NUDT5, 
GART, NME4, ITPA, NME1, PKM2, RRM2, 






PSMB10, SHFM1, PSMA7, PSMB5, PSMB4, 
PSMB7, PSMB6, PSMB1, PSMB3, PSMB2, 
PSMD3, PSMD4, PSMD6, PSMD7, PSMD8, 
PSMA2, PSMA1, PSMD14, PSMC5, PSMD13, 
PSMA6, PSMC4, PSMA5, PSMC3, PSMC2, 




POLR2H, POLR3G, POLR2G, POLR2F, 
NUDT2, POLR2E, POLR2K, POLR2J, DTYMK, 
PNPT1, POLR2I, POLA1, CAD, POLR2C, 
CMPK1, TK1, NME4, PRIM1, ITPA, NME1, 





Term Genes p_value FDR 
mmu05322:Systemic 
lupus erythematosus 
SNRPD1, CBX3, HIST2H2AA1, HIST1H2BP, 
HIST1H2BM, HIST1H2BN, H2AFV, 
HIST1H2BK, HIST1H2BL, HIST2H2AC, 
HIST1H2BJ, H2AFZ, HIST3H2A, H2AFX, 
ACTN1, ACTN3, H2AFJ, HIST2H4, 
HIST2H2BB, HIST1H2AB, HIST1H2AC, 
HIST1H4M, HIST1H4K, HIST1H2AF, 
HIST1H2AG, HIST1H2AD, HIST1H2AE, 
HIST2H3C2, TROVE2, HIST1H4A, HIST1H4B, 
HIST1H4F, HIST1H4C, HIST1H4D, HIST1H4I, 
HIST1H4J, HIST1H4H, HIST1H2BA, 
HIST1H2BB, HIST2H3B, HIST1H2BC, 
HIST1H2BE, HIST1H2BF, HIST1H2BG, 
HIST1H2BH, HIST1H3A, HIST1H3B, 
HIST1H2AI, HIST1H3C, HIST1H2AH, 
HIST1H3D, HIST1H2AK, HIST1H3E, 





ANAPC1, FZR1, DDB1, ANAPC4, SAE1, 
CDC20, CDC34, CDC16, SKP1A, UBE3C, 
CDC26, UBE2C, RBX1, TRIM37, PRPF19, 
UBE2E3, FBXW8, RNF7, CUL7, CUL4A, 








Term Genes p_value FDR 
mmu04260:Cardiac 
muscle contraction 
UQCRC2, ACTC1, UQCRC1, COX7A2, 
TNNC1, COX8A, CYC1, COX7B, COX7C, 
COX4I1, UQCRFS1, TPM2, COX5A, CACNG1, 
COX5B, COX6C, TNNT2, UQCR10, UQCR11, 




DLST, ACO2, ACO1, SUCLG2, SUCLG1, CS, 
DLAT, PDHB, IDH3A, SDHA, SDHB, IDH3G, 
SDHC, DLD, SDHD, IDH2, IDH1, FH1, 




POLA1, MCM2, RNASEH2A, MCM3, 
RNASEH2B, MCM4, MCM5, RNASEH2C, 
RPA3, MCM6, RPA1, PRIM1, RFC5, RPA2, 




BID, CDK1, CYCS, CDK6, PMAIP1, CDK4, 
CCNG1, SESN3, CCNB1, CCNE1, CCND1, 





ANAPC1, CDK1, ANAPC4, CDC20, SKP1A, 
CDC16, CDC26, RBX1, CCNB1, CCNE1, 
PPP1CA, YWHAH, MAD2L1, CCNB2, BUB1, 







LDHB, LDHA, ADH5, PGAM1, PGAM2, 
DLAT, GPI1, PDHB, ALDH3B1, PGM2, TPI1, 





EXOSC8, CNOT8, EXOSC9, EXOSC4, LSM7, 
PNPT1, EXOSC5, NAA38, LSM5, LSM4, 





Term Genes p_value FDR 
mmu03420:Nucleotide 
excision repair 
DDB1, GTF2H4, CETN2, GTF2H2, RBX1, 
RPA3, RFC5, RPA1, MNAT1, RPA2, RFC3, 




AKR1B8, ME1, LDHB, LDHA, ME2, PKM2, 






leucine and isoleucine 
degradation 
BCKDHA, ACAA2, ACADM, ACADS, DLD, 








LAP3, GSS, GSR, GPX1, GSTA4, RRM2, PGD, 







ACAA2, ACADM, ACADS, ADH5, ECHS1, 








LDHB, LDHA, ACADM, SUCLG2, SUCLG1, 







RARS2, RARS, HARS2, FARSB, LARS, GARS, 






and nucleotide sugar 
metabolism 
CYB5R3, PGM2, GALK1, CYB5R1, NANS, 







GOT2, LAP3, PYCRL, PYCR2, GOT1, ASS1, 







POLR2H, POLR3G, POLR2G, POLR2F, 






aspartate and glutamate 
metabolism 







serine and threonine 
metabolism 
SHMT1, SHMT2, GATM, DLD, PHGDH, 
















Term Genes p_value FDR 
mmu00360:Phenylalanine 
metabolism 





































leucine and isoleucine 
biosynthesis 













Figure 23. Mpp7 is highly expressed in control satellite cells and drastically reduced 
in SCsA-CREB (A) FPKMs of Mpp family proteins in SCs shows significant reduction of 


















Figure 24. pCREB binds to the Mpp7 promoter (A) Schematic of Mpp7 promoter 
including the loci of candidate CREB binding sites relative to the TSS. (B) pCREB 
occupancy at the Mpp7 promoter in primary myoblasts was analyzed by ChIP-qPCR. 
Percent of precipitated DNA compared to input DNA (not immunoprecipitated) shown. 








1 2 3 4 
1 -4783 to -4479 
2 -4610 to -4606 
3 +10 to +14 






































































Figure 25. Mpp7 is localized to the apical domain of SCs and reduced in SCsA-CREB 
(A) 3-dimensional (3-D) reconstruction of confocal images obtained from single 
myofiber-associated SCs. Letters mark b-basal, m-medial, a-apical planes parallel to the 
myofiber long axis and T-transverse plane orthogonal to the myofiber long axis. (B) 
Digital transverse slice obtained from 3-D reconstruction of SC. (C) Images rendered 
from basal (b), medial (m), and apical (a) planes delineated in (A). Mpp7 
immunofluorescence I.D. shows Mpp7 is enriched in the medial and apical domains. (D) 
Immunofluorescence analysis of single myofiber-associated SCs shows reduced levels of 
Mpp7 in SCsA-CREB. Green arrowheads mark apical domain. Dotted line marks basal 
lamina edge of myofiber. (E) Quantification of Mpp7 expression pattern in single 
myofiber-associated SCs. ##p<0.01, Chi-squared test. Scale bars 2 µm (A), 5 µm (B, D),  


























































Figure 26. Apically localized proteins are disrupted in SCsA-CREB Single myofiber-
associated SCs were isolated and immediately processed for immunofluorescence 
analysis. Loss of apically enriched M-cad (A,B), expression of Par-3 (D,E), and apically 
enriched β-cat (G,H) in SCsA-CREB. Quantification of polarized M-cad (C), Par-3 (F), and 
β-cat (I) expression. Unperturbed basally polarized expression of ITGB1 (J,K) in SCsA-
CREB.  (L) Quantification of polarized ITGB1 expression. N=3 mice/genotype, n≥50 









See Chapters 2 and 3 for mice used. 
Illumina cDNA sequencing (RNA-seq) 
High quality (RIN>9) total RNA was isolated from FACS sorted cells using Arcturus 
Pico kit, catalog #KIT0204, Applied Biosystems.  70 ng of total RNA was then used as 
starting material for Ribozero rRNA depletion, catalog #RZH1086, Epicentre (Illumina).  
cDNA was generated from this rRNA depleted sample following Illumna TruSeq DNA 
sample prep (low input), Illumina. 
Library read mapping  
For RNA-seq, reads were aligned to mm9 UCSC version 7 mouse genome.  Tuxedo 
protocol (Trapnell et al., 2012), Tophat and cufflinks, was followed to determine relative 
expression levels of genes.  2 biological replicates were used per experimental sample 
and control. 
ChIP-PCR 
Fragmented chromatin was obtained from 4x106 myoblasts grown in growth media (20% 
fetal bovine serum, 5% horse serum, 1% chicken embryo extract, PENSTREP, 1% 
Glutamax, bFGF) using Covaris truChIP low cell chromatin shearing kit, catalog 
#010145, Covaris.  Cells were fixed in 1% formaldehyde for 10 minutes and chromatin 
was sonicated using Covaris M22 Focused ultrasonicator, peak power 75, duty factor 5, 
cycles/burst 200, 6oC using 30 second pulses at 2 minute intervals at 6W for 8 minutes of 




anti-phospho-Ser133-CREB, catalog #9198 (87G3), Cell Signaling; anti-normal rabbit 
IgG, catalog #2729, Cell Signaling. Immunoprecipitated DNA was purified by QIAquick 
PCR Purification kit.  Primers used to detect Mpp7 promoter motif 1: 5’- CAG CGT 
CTG GCT ATG TGC C-3’, 5’- CCA GGC ATG ATA GCA CAT GG-3’; motif 2: 5’- 
TGC ACC TCC CAG CGA GAC-3’, 5’- GCT CAG CAG GAT GAA CTA GC-3’; motif 
3: 5’- GCT AGT TCA TCC TGC TGA GC-3’, 5’- CAG TCC AAG CGC CAC TTA G-
3’, motif 4: 5’- GTG TAA CAA GGA AGT GTG TGA TG-3’, 5’- CTT GCC TAA TAG 
GCA CAT GAC T-3’	
Single fiber isolation 
See Chapter 2 for methods used for obtaining single fibers. 
Antibodies 
Primary antibodies used were rabbit anti-Mpp7 (1:10), catalog #12983-1-AP, 
Proteintech; goat anti-Mpp7 (1:25), catalog #sc-163089, Santa Cruz; mouse anti-M-
cadherin (1:250), catalog #81471, Santa Cruz; rabbit anti-Par-3 (1:250), catalog #07-330, 
Millipore; mouse anti-β-catenin IgG1 (1:100), catalog #RDI-BCATENIN, RDI. See 



































Cellular quiescence and proliferation are regulated by polarity proteins in multiple stem 
cell systems (Florian and Geiger, 2010). The functional relevance of polarity during 
quiescence is unclear, however the importance of polarity during activation has been 
studied.  The polarity protein Mark2 (Par1b) is basally localized in activated SCs and 
regulates asymmetric division (Dumont et al., 2015). The Scrib polarity protein, localized 
basolaterally in epithelia (Su et al., 2012), is critical for promoting myoblast proliferation 
and differentiation (Ono et al., 2015). Polarity proteins mediate SC divisions and cell fate 
through activation of signaling pathways. p38α/β MAPK pathway is activated by the core 
apical polarity complex components Par-3 and PKCλ during SC expansion to promote 
transit amplification in vitro (Troy et al., 2012).  Given the requirement for polarity 
proteins during SC expansion, the significance of polarity during quiescence warrants 
further attention.  
 I found that Mpp7 polarity protein was the most highly down-regulated transcripts 
in SCsA-CREB (Table 2).  This defect in polarity could be a secondary effect of another 
misregulated gene.  In order to rule out this possibility, I tested the contribution of Mpp7 







Mpp7 expression rescues the proliferation and self-renewal defect of SCsA-CREB 
To test whether Mpp7 is a downstream mediator of CREB function in the SC, I 
introduced constructs for expressing Mpp7 together with bicistronic membrane-GFP 
(mGFP) or mGFP alone into SCsA-CREB on their myofibers; mGFP was used to follow 
transfected cells in conjunction with SCsA-CREB nGFP. Expression of Mpp7 increased 
SCsA-CREB proliferative cluster sizes and expanded both the Pax7+MyoD+ progenitor and 
Pax7+MyoD- self-renewed fractions (Figure 27A-C). In parallel, I transfected the same 
constructs into unmarked wild-type SCs. Mpp7 expression did not alter proliferative 
cluster sizes, but rather increased the fractions of Pax7+MyoD+ progenitors and 
Pax7+MyoD- self-renewed SCs (Figure 27A-C). Importantly, Mpp7 rescued the 
proliferative cluster size profiles, Pax7+MyoD+ fractions and Pax7+MyoD- fractions of 
SCsA-CREB to levels equivalent to those in control SCs expressing mGFP alone (Figure 
27). These data support Mpp7 is not only a target but also a functional mediator of CREB 
activity.  
I next tested whether Mpp7 knockdown by siRNA is sufficient to cause an 
expansion defect in control YFP+ cells. I was not able to achieve successful siMpp7 
knockdown in myofiber cultures, therefore I turned to SC-derived myoblasts, which also 
display high CREB activity (Figure 4A,B) and express Mpp7 (Figure 25). As expected, 
A-CREB expression in SC-derived myoblasts showed compromised proliferation and 
increased differentiation (Figure 28). I tested 3 siRNAs against Mpp7 transcripts and the 




incorporation and increased Mgn expression relative to scrambled control siRNA (Figure 
30). All together, these data indicate that Mpp7 is a major downstream mediator of CREB 







Polarity protein Mpp7 is highly downregulated (Figure 23) and apically localized 
proteins are also distributed aberrantly (Figure 26A-I) in SCsA-CREB.  Interestingly, Par-3, 
an activation promoting polarity protein, is absent or reduced in in SCsA-CREB (Figure 
26D-F) suggesting that an overall defect in polarity may contribute to the lack of 
proliferation and self-renewal of SCsA-CREB. I found that re-expressing Mpp7 alone is 
sufficient to restore the ability of SCsA-CREB to proliferate and self-renew (Figure 27).  
Interestingly, overexpression of Mpp7 in wild-type SCs also increased the proportion of 
self-renewing and progenitors populations (Figure 27) although proliferation did not 
change.  The ability for Mpp7 to positively direct proliferation and self-renewal is a novel 
function for Mpp family of proteins and a novel role for a polarity protein in quiescent 
SCs.  Given the high level of Mpp7 during quiescence and polarity defect of SCsA-CREB, 
these data provide evidence that setting up a polarity during quiescence affects future 


























































Figure 27. Overexpression of Mpp7 in SCsA-CREB cells rescues proliferation defect 
and Pax7+ cell population loss (A) EDL single fibers and associated SCs of A-CREB 
and CD1 mice were transfected with Mpp7::mGFP or mGFP and cultured in plating 
medium for a total of 4 days. Representative images of clonal clusters showing cluster 
size and Pax7-/MyoD+, Pax7+/MyoD-, or Pax7+/MyoD+ expression patterns. (B) 
Quantification of clonal cluster size after transfection with Mpp7::mGFP or mGFP. (C) 
Quantification of Pax7-/MyoD+, Pax7+/MyoD-, or Pax7+/MyoD+ expression patterns after 










Figure 28. CREB inactivation in cultured myoblasts causes reduced proliferation 
and premature differentiation Primary myoblasts harvested from 
Pax7CE/+;Rosa26YFPYFP and Pax7CE/+;Rosa26A-CREB/A-CREB (TAM-) mice were cultured in 
growth medium for 1 passage and treated with 1µM 4-Hydroxytamoxifen for 24 hours. 
(A)  Quantification of Pax7+, EdU+ or Mgn+ lineage marked myoblasts 24 hours after 4-




















Figure 29. siRNA targeting Mpp7 transcripts reduces Mpp7 levels (A) 3 siRNAs 
targeting different regions of the Mpp7 transcript were tested for ability to reduce Mpp7 
levels as detected by qRT-PCR. Data represented as mean +/- 1 standard deviation. 
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Figure 30. Knockdown of Mpp7 transcripts leads to reduced proliferation and 
enhanced differentiation of cultured myoblasts TAM-treated YFP SCs were harvested 
and cultured in growth medium.  Cell were transfected twice in 24 hour increments with 
indicated siMpp7 combinations. Analysis was performed 24 hours after last transfection.  
(A) Representative images of immunofluorescence detection of EdU and Mgn in siMpp7 
and siScr (control) experiments. (B) Quantification of EdU incorporation and Mgn 












































See Chapters 2 and 3 for mice used. 
Single fiber isolation 
See Chapter 2 for methods used for obtaining single fibers. 
Plasmids 
The backbone vector pMIGR1 (Pear et al., 1998) was modified to replace the GFP gene 
with EGFP-CAAX (membrane GFP, mGFP) to serve as a control.  Human Mpp7 cDNA 
with a V5 C-terminal tag was cloned into the pMIGR1-mGFP to produce pMIGR1-
V5Mpp7-IRES-mGFP.  Each plasmid expresses membrane GFP as a reporter for 
transfection efficiency. 
siRNAs 
siRNAs targeting mouse Mpp7 were purchased from Life Technologies, catalog #s: 
s93843 (#1), s93844 (#2),s93845 (#3), and resuspended to 20 μM working concentration.  
Silencer Select Negative Control siRNA, catalog #4390843, Life Technologies, was used 
as a control. 
qPCR and primers 
Total RNA was isolated from cells using Arcturus Pico kit, catalog #KIT0204, Applied 
Biosystems.  cDNA was generated following standard methods using NEB M-MuLV 
Reverse Transcriptase, catalog #M0253S, New England BioLabs. Quantitect SYBR 
Green PCR Kit reagent, catalog #204141, Qiagen, was used in quantitative PCR reactions 
in a BioRad Thermocycler, catalog #CFX96 PCR, BioRad, for PCR product detection.  




CAT G-3’ and reverse: 5’-ACA CGT CCC AGA GGA AGG TC-3’. 18S RNA levels 
were determined using primers forward: 5’-GTA ACC CGT TGA ACC CCA TT-3’ and 
reverse 5’-CCA TCC AAT CGG TAG TAG CG, as an internal control. 
Single fiber transfection of plasmids 
Single fibers were isolated as described in Chapter 2 and cultured in, growth media (20% 
fetal bovine serum, 5% horse serum, 1% chicken embryo extract, PENSTREP, 1% 
Glutamax, bFGF), for 8 hours on horse serum coated tissue culture dishes.  Transfection 
solution was prepare at using TransfeX reagent, catalog#ACS-4005, ATCC, at 
DNA(ug):Transfex TransfeX reagent, at 1:2 ratio for 12 hours.  Media was changed to 
plating media for the remainder of the culture for a total of 4 days after initial harvest. 
Myoblast transfection of siRNAs 
Plated myoblasts were cultured on matrigel coated tissue culture dishes and grown to 
50% confluency prior to transfection.  siRNAs were diluted in OPTIMEM and combined 
with Lipo 3000 reagent at 1:1 ratio following manufacture’s protocol, catalog 
#L3000008, Life Technologies.  Transfections were performed for 6 hours after which 
fresh plating media (10% horse serum, 0.5% chicken embryo extract, 1XPENSTREP, 1% 
Glutamax) was added to cells.  24 hours after the first transfection, a second transfection 
under the same conditions was performed.  24 hours after second transfection, myoblast 
were analyzed. 
Antibodies 





EdU was added to tissue culture media at 10 µM final concentration for 2 hours prior to 
analysis. 
EdU detection 
































The Hippo pathway effector YAP promotes myoblast proliferation and inhibits 
differentiation (Judson et al., 2012; Tremblay et al., 2014). Interestingly, polarized 
subcellular Angiomotin (AMOT) distribution differentially regulates Hippo signaling to 
direct YAP-dependent cell fate in pre-implantation embryos (Hirate et al., 2013; Leung 
and Zernicka-Goetz, 2013). YAP is repressed by core Hippo pathway kinases Mst1/2 and 
Lats1/2 YAP (Pan 2010), whereas it is either activated or repressed by AMOT family of 
proteins (consisting of AMOT, AMOTL1, and AMOTL2), depending on the cellular 
context (Chan et al., 2011; Yi et al., 2013; Zhao et al., 2011). Discriminating factors 
modulate AMOT activity and a seminal study identified Par-3, AMOTL1, AMOTL2, and 
tight junction associated Drosophila Stardust homologs, Mpp5 and Mpp7 to be AMOT 
binding partners (Wells et al., 2006). Whether Mpp7, and AMOT affect YAP activity in 
SCs in unknown. Moreover, the transcriptional regulation of polarity genes has not been 







Mpp7 and AMOT regulate myoblast proliferation and YAP nuclear accumulation  
I next sought to determine the mechanism by which how Mpp7 regulates proliferation. 
Among the Mpp7 protein interactions (Bohl et al., 2007; Stucke et al., 2007; Wells et al., 
2006), an AMOT-containing complex (Wells et al., 2006) is of particular interest due to 
the critical role for AMOT in regulating Par-3 and YAP, both known proliferation 
regulators of SCs (Judson et al., 2012; Troy et al., 2012). Like Mpp7, AMOT is localized 
to the apical side of quiescent SCs (Figure 31A-E). By double labeling, I found 
overlapping signals between Mpp7 and AMOT (Figure 31D,E). Proximity ligation assay 
(PLA) confirmed this apical interaction between Mpp7 and AMOT (Figure 32).  
Furthermore, a portion of Mpp-AMOT and Mpp7-YAP PLA signals were localized to the 
SC nucleus of a portion of SCs (Figure 32,33,34), suggesting a possible role of AMOT 
and Mpp7 for YAP nuclear shuffling, previously observed in hepatocytes (Yi et al., 
2013). Most SCsA-CREB displayed reduced AMOT (Figure 35) even though AMOT 
transcripts were not reduced (Figure 36), suggesting a translational or post-translational 
change. For the subset that exhibited a detectable level of AMOT, the expression pattern 
was almost exclusively non-polarize (Figure 35B). I next examined whether YAP also 
displayed aberrant expression. I found YAP accumulated in the nucleus in control 
quiescent SCs, but it was severely reduced in SCsA-CREB (Figure 37A,B). The lack of 
YAP target genes (Piccolo et al., 2014) in the SCsA-CREB down-regulated group (Table 2) 
suggests that YAP’s transcriptional action is minimal in quiescent SCs, but becomes 




A constitutively active form of YAP, that can accumulate in the nucleus, 
enhanced proliferation and reduced differentiation of C2C12 and SC-derived myoblasts 
(Judson et al., 2012; Watt et al., 2010). To test whether Mpp7 and AMOT, as well as 
other potential regulators, play a role in YAP nuclear accumulation of myoblasts, I used 
an RNAi approach. After testing 3 different siRNAs per gene (Figure 38), I selected the 
siRNA with the most effective knockdown for the remainder of experiments. RNAi of 
Mpp7, AMOT, or AMOT family members AMOT-L1 and AMOT-L2, each caused 
reduction of EdU+ proliferating and Pax7 expressing cells, while increased Mgn+ cells 
(Figure 39). Additionally, nuclear YAP was reduced (Figure 40).  Confirming previous 
work, RNAi of YAP strongly reduced myoblast proliferation and Pax7+ cells, while 
increased Mgn+ cells (Figure 39). Furthermore, RNAi of Mpp7 caused down-regulation 
of canonical YAP downstream genes (Figure 41). To test the contribution of the Hippo 
pathway, I targeted Lats1 and Lats2, the immediate upstream kinase negative regulators 
of YAP. RNAi of Lats1 and/or Lats2 enhanced proliferation, nuclear YAP, and Pax7 
expression without affecting Mgn expression (Figure 39,40). The similarities among 
Mpp7, AMOT family and YAP RNAi, and the biochemical data of Mpp7-AMOT family 
(Wells et al., 2006) and AMOT-YAP (Chan et al., 2011; Yi et al., 2013; Zhao et al., 
2011) protein complexes led me to propose that they form a regulatory axis that promotes 







Here, I have shown that Mpp7 directs an AMOT-YAP axis to regulate SC proliferation 
and Pax7 expression.  Previous studies showed that Mpp7 and AMOT family members 
interact in HEK293T cells (Wells et al., 2006) and consistently I found that Mpp7 
interacts with AMOT in SCs (Figure 32,33,34).  Based on previous studies of AMOT and 
YAP interactions, the effect of AMOT on YAP activity could be either positive or 
negative depending on cellular context (Chan et al., 2011; Yi et al., 2013; Zhao et al., 
2011). My data provides evidence for the former, in which AMOT is a positive regulator 
of YAP (Figure 40).  This is consistent with the idea that overexpression of AMOT 
family members in cell lines might have a negative effect on YAP whereas biologically 
relevant levels of AMOT positively regulate YAP (Yi et al., 2013).  In summary these 
data show that Mpp7 is a positive regulator of AMOT in the SC to promote YAP 
signaling. 
 The mechanism by which AMOT regulates YAP has been controversial.  The 
sequestering of YAP by AMOT in the cytoplasm has been suggested (Chan et al., 2011, 
2013; Wang et al., 2011; Zhao et al., 2011) as well as enhancing YAP nuclear entry by 
AMOT to promote YAP downstream target gene activation (Yi et al., 2013).  SCs show 
nuclear localization of Mpp7-YAP interactions, indicating that Mpp7 may also be 
involved in the nuclear transport of YAP.  Based on my localization studies, Mpp7 is 
found both on the apical membrane as well as the nucleus, and one scenario for YAP 
regulation may be that Mpp7 can promote transport of YAP into the nucleus, or at least 


















































Figure 31. AMOT is localized to the apical domain of SCs (A) 3-dimensional (3-D) 
reconstruction of confocal images obtained from single myofiber-associated SCs. Letters 
mark b-basal, m-medial, a-apical planes parallel to the myofiber long axis and T-
transverse plane orthogonal to the myofiber long axis. (B) Representative image of 
digital transverse slice of SCs obtained from 3-D reconstruction. (C) Images rendered 
from basal (b), medial (m), and apical (a) planes delineated in (A). AMOT 
immunofluorescence I.D. shows AMOT is enriched in the medial and apical domains. 
(D) Immunofluorescence analysis of AMOT and Mpp7 expression in single myofiber-
associated SCs shows partial  colocalization. Green arrowheads mark apical domain. 
Dotted line marks basal lamina edge of myofiber. (E) Quantification of AMOT/Mpp7 
expression pattern in single myofiber-associated SCs. Scale bars 2 µm (A), 5 µm (B),  6 








Figure 32. Direct binding between Mpp7 and AMOT proteins in SCs (A) 
Representative image of SCs after performing Proximity ligation assay (PLA) showing 
colocalization of Mpp7 and AMOT proteins within the apical domain (upper panel) and 
nuclear domain (lower panel) of SCs. Dotted line marks basal lamina edge of myofiber. 
Green lines indicate the region that is boxed to the right.  Boxed region represents an 
orthogonal view, relative to the long axis of the myofiber, of the SC. (B) Quantification 






































Figure 33. Direct binding between Mpp7 and YAP proteins in SCs (A) Proximity 
ligation assay (PLA) reveals colocalization of Mpp7 and YAP proteins within nuclear 
and perinuclear domains of SCs. Green lines indicate the region that is boxed to the right.  
Boxed region represents an orthogonal view, relative to the long axis of the myofiber, of 
the SC. (B) Quantification of sub-cellular localization of Mpp7-YAP complexes in SCs. 



























Figure 34. Proximity ligation assay control using single Mpp7 primary antibody 
recognition (A) Using Mpp7 antibody and omitting second antibody showed no PLA 
reaction in WT myofiber-associated SCs. Green lines indicate the region that is boxed to 
the right.  Boxed region represents an orthogonal view, relative to the long axis of the 






















Figure 35. SCsA-CREB show reduced AMOT expression and AMOT apical 
localization (A) Immunofluorescence analysis of AMOT expression in single myofiber-
associated SCs shows loss of apically localized AMOT expression in A-CREB SCs 
compared to YFP control. Green arrowheads mark apical domain. Dotted line marks 
basal lamina edge of myofiber. (B) Quantification of subcellular AMOT localization 



























Figure 36. AMOT family and Hippo pathway transcripts are not significantly 















Figure 37.  SCsA-CREB show reduced nuclear YAP localization (A) 
Immunofluorescence analysis of YAP expression in single myofiber-associated SCs 
shows loss of nuclear YAP in SCsA-CREB compared to YFP. White arrow marks 
myonuclei. Dotted line delineates SC nucleus. I.D. ratio calculated as SC nuclear YAP 
fluorescence integrated density as a fraction of average myonuclear fluorescence 
integrated density. (B) Quantification of nuclear YAP expression within YFP SCs or 
SCsA-CREB. ##p<0.01, Chi-squared test. Scale bar 30 µm. 






















Figure 38. Efficiency of knockdown using siRNAs targeting AMOT family and 
Hippo pathway components  WT SCs were harvested and cultured in growth medium.  
Cell were transfected twice in 24 hour increments with indicated siRNAs. Analysis was 
performed 24 hours after last transfection.  Quantification of AMOT (A), AMOTL1 (B), 
AMOTL2 (C), Lats1 (D), Lats2 (E), and YAP (F) transcripts as fold change relative to 
control siScr by qRT-PCR. Data represented as mean +/- 1 standard deviation. *p<0.05, 
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Figure 39. Mpp7 protein, AMOT family and Hippo pathway components contribute 
to myoblast proliferation and differentiation (A) TAM-treated YFP SCs were 
harvested and cultured in growth medium.  Cell were transfected twice in 24 hour 
increments with indicated siRNAs. Analysis was performed 24 hours after last 
transfection.  Quantification of Pax7 expression (A), EdU incorporation (B), and Mgn 
expression (C). Data represented as mean +/- 1 standard deviation. *p<0.05,**p<0.01, 


























































Figure 40. Nuclear accumulation of YAP depends on Mpp7 protein, AMOT family 
and Hippo pathway component levels in primary myoblasts TAM-treated YFP 
satellite cels were harvested and cultured in growth medium.  Cell were transfected twice 
in 24 hour increments with indicated siRNAs. Analysis was performed 24 hours after last 
transfection.  (A) Representative images of immunofluorescence detection of nuclear 
YAP in siMpp7 and siScr (control) experiments. (B) Quantification of nuclear YAP after 
transfection using indicated siRNA . Data represented as mean +/- 1 standard deviation. 



































Figure 41. Knockdown of Mpp7 reduces YAP target gene expression (A) TAM-
treated YFP SCs were harvested and cultured in growth medium.  Cell were transfected 
twice in 24 hour increments with siMpp7. Analysis was performed 24 hours after last 
transfection.  (A) Quantification of indicated transcripts by qRT-PCR after siRNA 





















Figure 42. CREB family is expressed in SCs (A) FPKMs of CREB family members of 










See Chapters 2 and 3 for mice used. 
Single fiber isolation 
See Chapter 2 for methods used for obtaining single fibers. 
Antibodies 
Primary antibodies use were rabbit anti-AMOT, catalog #sc-98803, Santa-Cruz; rabbit 
anti-YAP/TAZ, catalog #8418S, Cell Signaling. See Chapter 2,3, and 6 for additional 
antibodies used. 
Proximity Ligation Assay (PLA) 
Single fibers were obtained using the methods described in Chapter 2.  Primary antibody 
application was performed as described in Chapter 2.  PLA was performed per 
manufacture’s protocol, Duolink In Situ Red Started Kit Goat/Rabbit, catalog 
#DUO92105, Sigma.  In short, after primary antibody application, PLUS and MINUS 
PLA probes were added to samples and then a ligation reaction performed to join probe 
ends.  Amplification of the probe linkers were performed in the presence of fluorescently 
labeled nucleotides for detection of protein-protein proximity.  Secondary antibody 
application was performed as described in Chapter 2.  Samples were mounted under 
coverslips using Duolink in situ fluorescence medium, provided in the kit.  For the 
negative control reaction, only one primary antibody was used and the same protocol was 
performed as described above. 




See Chapter 7 for methods for cDNA generation, qPCR, and primers for detecting Mpp7 
transcripts.  AMOT transcript was detecting using primers forward: 5’- CCG CCA GAA 
TAC CCT TTC AAG -3’ and reverse: 5’- CTC ATC AGT TGC CCC TCT GT -3’; 
AMOTL1 transcript was detecting using primers forward: 5’- ATG TAG CCT CTG GAA 
GAG TGT -3’ and reverse: 5’- TGA GTG AGG GTT TCC GTG GA -3’; AMOTL2 
transcript was detecting using primers forward: 5’- GGA GAA GAG TTG CCC ACC 
TAT -3’ and reverse: 5’- TCG AAG AGC TTC ATC CTG TCG -3’; YAP1 transcript was 
detecting using primers forward: 5’- ACC CTC GTT TTG CCA TGA AC -3’ and 
reverse: 5’- TGT GCT GGG ATT GAT ATT CCG TA -3’; Lats1 transcript was detecting 
using primers forward: 5’- AAA GCC AGA AGG GTA CAG ACA -3’ and reverse: 5’- 
CCT CAG GGA TTC TCG GAT CTC -3’; Lats2 transcript was detecting using primers 
forward: 5’- GGA CCC CAG GAA TGA GCA G -3’ and reverse: 5’- CCC TCG TAG 
TTT GCA CCA CC -3’; ANKRD1 transcript was detecting using primers forward: 5’- 
TAA TCG CTC ACA ATC TGT TGA CA -3’ and reverse: 5’- GCC TCT CAC CTT 
CCG ACC T -3’; Areg transcript was detecting using primers forward: 5’- GCA GAT 
ACA TCG AGA ACC TGG -3’ and reverse: 5’- CTG CAA TCT TGG ATA GGT CCT 
TG -3’; Birc5 transcript was detecting using primers forward: 5’- CTG GGA ACC CGA 
TGA CAA C -3’ and reverse: 5’- TGG CTC TCT GTC TGT CCA G -3’; CTGF 
transcript was detecting using primers forward: 5’- GGG CCT CTT CTG CGA TTT C -
3’ and reverse: 5’- ATC CAG GCA AGT GCA TTG GTA -3’. 18S RNA transcript levels 







See Chapter 7 for siRNA targeting mouse Mpp7. The following siRNAs were purchased 
from Life Technologies targeting mouse AMOT, catalog #s: s77828 (#1),s77829 (#2), 
s77830 (#3); mouse AMOTL1, catalog #s: s93825(#1), s93826(#2), s93827(#3); mouse 
Lats1, catalog #s: s201588 (#1), s201589 (#2), s201590 (#3); mouse Lats2, catalog #s: 
s78350 (#1), s78351 (#2), s78352 (#3), mouse YAP1, catalog #s: s76159 (#1), s76160 
(#2), s202423 (#3). siRNAs targeting mouse AMOTL2 were purchased from Sigma, 
catalog #s: SASI_Mm02_00324945 (#1), SASI_Mm02_00324945 (#2), 
SASI_Mm02_00324945 (#3). All siRNAs were resuspended at a 20 μM working 
concentration. 
EdU treatment 
See Chapter 7 for methods on EdU application. 
EdU detection 

































Here I provide evidence that CREB activity in quiescent SCs directs Mpp7 expression, 
which in turn maintains the protein level and/or localization of known (Par-3 and YAP) 
and new (AMOT) SC regulators. Given CREB activity, as well as Mpp7 and AMOT 
expression extend into the period of myoblast activation, CREB-Mpp7-AMOT forms a 
previously uncharacterized regulatory axis that endows quiescent SCs with the 
competence to initiate expansion and maintain proliferative capacity of SC-derived 
myoblasts. 
Muscle regeneration requires CREB activity 
I found that pCREB displays dynamic changes during myogenic progression, extending 
previous reports for CREB activity in myogenic progenitors and myoblasts (Chen et al., 
2005; Stewart et al., 2011). Although crushed muscle extracts and bFGF could stimulate 
pCREB in myoblasts (Stewart et al., 2011), neither was included in our culture.  High 
pCREB levels in SCs and myoblasts are thus induced by myofibers, serum factors, or 
cell-cell paracrine signals. As all three CREB members are expressed in the SC lineage 
(Figure 42) they likely all contribute to the pCREB signal of SCs and myoblasts (Figure 
1,3,4).  
Instead of inactivating the combined 6 alleles of this gene family, I used A-CREB 
to selectively inhibit their activity collectively (Ahn et al., 1998) in the SC and found that 
regeneration was severely compromised  by CREB inhibition. My observation that CREB 
activity is required for SC proliferation and self-renewal extends the gain-of-function 
data that CREB-YP enhances myoblasts proliferation (Stewart et al., 2011). Additionally, 




studied.  The requirement for CREB in the regeneration of myofibers (Figure 9,10) can 
be directly related to its role in proliferation.  However the finding that CREB can direct 
self-renewal was a surprise.  Not only did CREB affect the number of total Pax7+ cells, 
which could represent both Pax7+ progenitor and self-renewing population, CREB 
maintains the ability to selectively enhance Pax7+/MyoD- self-renewing cells (Figure 12, 
18).  This is the first time CREB has been shown to direct SC cell fate. 
Mpp7 mediates CREB activity 
Using a comparative RNA-seq approach, I identified Mpp7 as a downstream target of 
CREB in SCs (Figure 23). This provided initial evidence that Mpp7 was mediating the 
effects of CREB inhibition.  I validated this hypothesis by performing rescue experiments 
whereby re-expressing Mpp7 alone is sufficient to restore the ability of SCsA-CREB to 
proliferate and self-renew (Figure 27). Ectopic Mpp7 in control cells increases self-
renewed SCs, but does not force myogenic expansion (Figure 27). One possibility is that 
the Mpp7-directed pathway is sufficient to drive self-renewal but it needs cooperation 
with additional signaling inputs for extra proliferative cycles and those inputs are limiting 
in culture. For example, HGF and FGF signaling are well known pathways for SC 
proliferation. Further exploration of the intersection and cooperation between Mpp7 and 
other SC proliferation regulators is needed. 
CREB-Mpp7-AMOT axis endows quiescent SC the competence for expansion 
Notably, the CREB-Mpp7-AMOT regulatory axis is established in quiescent SCs, while 
its inhibition seems to not affect Pax7 expression (Figure 6) or niche retention (Figure 7). 
Loss of Par-3, an apical determinant, likely causes the loss of apical restriction of M-




fewer proliferative myoblasts and fewer differentiated cells in vitro (Troy et al., 2012), 
This is in correspondence with the lack of proliferation in Mpp7 knockdowns, however 
they differ in that shPar-3 promotes the Pax7+ cell fate (Troy et al., 2012) whereas Mpp7 
knockdown promotes differentiation. Notably, because of the time for isolation and 
expression of shRNA, the nature of Par-3 loss during quiescence is unclear and should 
not be compared to Mpp7 loss in the SCsA-CREB model.  As M-cadherin and β-catenin 
have not been shown to be important for SC quiescence, their loss or changes may indeed 
have little impact on quiescent SCsA-CREB.  In summary, the loss of Mpp7 in the SC 
differs from studies identifying quiescence molecules, and instead provides evidence for 
an apical polarity regulator that allows for and maintains proliferation after activation. 
More intriguing is the CREB-Mpp7-AMOT axis for regulation of YAP in 
quiescent SCs. YAP is detected in the nucleus of quiescent SCs, however YAP-directed 
proliferation is not operational (Figure 7,37). Recent studies have established an 
alternative concept that retention of quiescence relies on the active suppression of 
activation rather than passive preservation. Through the activity of microRNAs, 
chromatin modifiers and cell surface receptors SCs preserve a mitotically inactive state 
(Boonsanay et al., 2016; Cheung et al., 2012; Crist et al., 2012; Yamaguchi et al., 2015). 
SCsA-CREB show defects in the apical domain during quiescence, however SCsA-CREB 
exhibits a distinct phenotype from these SCs with inactivated quiescence program. SCsA-
CREB show no mitotic activity nor differentiation during quiescence and maintain Pax7 
expression and position in the SC niche (Figure 7). SCsA-CREB manifests myogenic 




Given that YAP localizes to the SC nucleus during quiescence while its 
downstream targets are not significantly downregulated upon A-CREB expression (Table 
2), YAP must be prevented from action. I envision that YAP or its DNA binding co-
factors TEAD1 and TEAD3, the only family members of the TEAD family expressed 
during quiescence (Figure 42) are prevented from accessing their target genes by the 
quiescent facultative heterochromatin and/or from inhibitory co-factors. In either 
scenario, the CREB-Mpp7-AMOT axis promotes YAP nuclear entry, which primes SCs 
for activation upon injury stimulus and perpetuates proliferative potential during transit 
amplification of myoblasts. 
Mpp7-AMOT complex acts as a molecular scaffold for Par-3 and YAP signaling    
In epithelial cell lines, Mpp7 associates with Dlg1 or Crb3-Mpp5m the core adherence 
and tight junction signaling components, respectively, and regulates the function of tight 
junctions (Bohl et al., 2007; Stucke et al., 2007). Here I focused on a lesser-studied link 
between Mpp7 and AMOT. Proteomic analysis of AMOT binding partners revealed two 
complexes: one containing the core tight junction regulators Rich1, Crb3, PATJ, and 
Mpp5 (AMOT-tight junction complex), and the other, AMOT-L1, AMOT-L2, Mupp1, 
and Mpp7 (Mpp7-AMOT complex) (Wells et al., 2006). The same study established a 
physical association between AMOT and Par-3 and their role in maintenance of tight 
junctions, but the Mpp7-AMOT complex was not explored. In SCsA-CREB, Mpp7, AMOT 
and Par-3 staining signals are greatly diminished (Figure 25,26,31). Because only Mpp7’s 
transcript level is reduced among them (Figure 23) the protein stability of AMOT and 




All components of the Mpp7-AMOT complex, but not all of those in the AMOT-
tight junction complex, are expressed in the quiescent SCs, (Figure 23, 36). AMOT, as 
well as AMOT-L1 and AMOT-L2, have been shown to bind YAP and its related protein 
TAZ (Chan et al., 2011; Zhao et al., 2011). Current models in cell culture systems 
position AMOT as a cytoplasmic and tight junction localized binding partner of YAP, 
which restricts its activity by retaining it from the nucleus (Chan et al., 2011; Wang et al., 
2011; Zhao et al., 2011). However, AMOT has been proposed to act positively to regulate 
YAP activity in vivo (Yi et al., 2013). Interestingly, YAP/TAZ can act synergistically 
with Pax7 for enhancing induction of Pax3, Mitf, and Myf5 enhancer reporter constructs 
(Manderfield et al., 2014) suggesting AMOT-mediated YAP activity could be directly 
affecting the transcriptional activity of Pax7 to promote self-renewal of SCs. SCsA-CREB 
have concomitant loss of Mpp7, AMOT, and YAP levels. RNAi data indicate that Mpp7, 
AMOT, AMOT-L1 and AMOT-L2 all contribute to nuclear accumulation of YAP in 
myoblasts. Thus, the Mpp7-AMOT complex acts as a positive regulator of YAP for adult 
myogenic expansion. I propose that Mpp7-AMOT complex is an alternative scaffold for 
the conventional AMOT-tight junction signaling complex for YAP and acts in parallel 
yet coordinated fashion with Par-3 signaling to drive SC proliferation and self-renewal 































CHAPTER 10: EXCERPT FROM: A SERIES OF CRE-ER(T2) DRIVERS FOR 
MANIPULATION OF THE SKELETAL MUSCLE LINEAGE 
 
The following text and accompanying figure were published in: 
Southard, S., Low, S., Li, L., Rozo, M., Harvey, T., Fan, C.-M. and Lepper, C. (2014), A 
series of Cre-ERT2 drivers for manipulation of the skeletal muscle lineage. Genesis, 
52: 759–770. doi: 10.1002/dvg.22792 
 





For the Myod1CE allele, we did not observe cell marking by tmx at E8.75, but found cell 
marking in the lateral edge of inter-limb somites when tmx was administered at E975 
(Fig. 3A). Given the perdurance of tmx of ∼ 12 h in vivo (Nakamura et al., 2006), this 
period overlaps with the earliest Myod1 expression timing and pattern (Sassoon et al., 
1989). Progressively more facial and distal limb muscles were labeled at later stages (Fig. 
3B-F). Eight to sixteen hours long X-gal reactions were needed to observe signals in 
these Myod1CE embryos, likely reflecting that Myod1CE marks mostly differentiating 
muscle cells that did not expand. Alternatively, lower levels of CE may be produced by 
Myod1CE compared to Pax3CE .The E13.75 to E15.25 treated embryos appeared to have 
less intense staining, likely due to lower substrate penetrance through the skin (Fig. 3E). 
Removal of skin from E14.75 to E16.25 treated embryos indeed increased staining signal 
(Fig. 3F). As E10.75 represents a time of robust labeling, we chose this time point for a 
longer term tracing to E16.25. These embryos showed staining of the trunk and body wall 
muscles as well as subcutaneous muscles (Fig. 3G). Although both fore and hind limb 
muscles were positive, the fore limb muscles showed a stronger staining, consistent with 
the more advanced developmental stage at E10.75 (the labeling time). The observation of 
strong staining after a 6-day chase suggests that minimally a fraction of myogenic 
progenitors at E10.75 were labeled by tamoxifen in the Myod1CE embryos and 
subsequently amplified; thus, resulting in an expanded population of lineage-marked 
myogenic cells (in comparison to other CE alleles that did not display such a persistence, 
see below). This observation is consistent with the report that Myod1Cre (constitutive Cre 
KI at the Myod1 locus) directs lineage marking of muscle stem cells (Kanisicak et al., 




whole mount analyses. Although there was no staining of the heart (Fig. 3I), differential 
staining in different muscle groups was obvious, with the soleus (Fig. 3L) showing the 
lowest staining signal among gastrocnemius, plantaris, TA, and Extensor Digitorum 
Longus (EDL) muscles (Fig. 3J,K,M,N). Differential Myod1 expression levels among 
adult limb muscles and fiber types have indeed been reported (Hughes et al., 1993, 1997). 
Cross section of the TA muscles showed a mosaic pattern of labeling intensity (Fig. 3O), 













Myod1CE characterization. Time of tmx administration and embryo harvest is as in 
Figure 2. (A–F) Embryos (saggital view) were subjected to X-gal reactions (8–16 h); 
insets are control embryos; embryo in (F) was skinned. (G) Transverse section of the 
embryo at the brachial level, and (H) fore limb (FL, left) and hind limb (HL, right) 
levels (24 h reaction); sc, spinal cord; s, scapula; h, humerus; u, ulna; f, femur. (I–N) 
Adult muscles subjected to whole mount X-gal reactions (overnight); muscle names at 
bottom. Corresponding muscles from animals without tmx treatment (inset in J, and left 
muscles in K–M) were photographed side by side. (O) Cross section of TA muscles 
stained for X-gal (overnight) and Nuclear Fast Red. Open stars, facial muscles; arrows, 





















CHAPTER 11: EXCERPT FROM: MAKING SKELETAL MUSCLE FROM 
PROGENITOR AND STEM CELLS: DEVELOPMENT VERSUS 
REGENERATION 
 
The following was published in: 
Fan, C.-M., Li, L., Rozo, M. E., & Lepper, C. (2012). Making Skeletal Muscle from 
Progenitor and Stem Cells: Development versus Regeneration. Wiley Interdisciplinary 
Reviews. Developmental Biology, 1(3), 315–327. 
 





Myogenic induction by Wnt proteins 
In the embryo, the spinal cord and surface ectoderm surrounding the somite are necessary 
and sufficient for inducing myogenesis17,61-63. Several Wnt genes are expressed in these 
two tissues. Co-cultures of presomitic cells and cells producing selective Wnt proteins 
induce expression of Pax3 and Pax764, as well as Myf5 and MyoD65,66. In accordance, 
Wnt1;Wnt3a (both normally expressed in the dorsal spinal cord) double mutant embryos 
have reduced expression of Pax3 and Myf5 in the medial dermomyotome67. The 
myogenic inducing potential of Wnt genes expressed by the surface ectoderm has not 
been tested genetically. In vitro pharmacological studies suggest that Wnts activate the 
Gα - adenylyl cyclase - protein kinase A signaling cascade to phosphorylate the 
transcription factor CREB, which in turn activates myogenic genes. Consistently, both 
germ line inactivation of Creb and dominant negative Creb over-expression in the somite 
lead to severely reduced expression of Pax3, Myf5, and MyoD in vivo66. In addition, the 
PKC pathway, which can be activated via Gα signaling, has also been implicated in 
myogenic induction by modulating Pax3 activity and MyoD expression68. 
The canonical Wnt/β-catenin pathway also plays a role in myogenesis. 
Inactivation of β-catenin in presomitic mesoderm cells leads to disorganized somites due 
to segmentation defects69, disallowing a firm conclusion about its role in the primary 
wave of myogenesis70. En1-Cre directed β-catenin inactivation in the central 
dermomyotome leads to an increase in the domain of myogenic cells at the expense of 
dermal cells, indicating an inhibitory role of β-catenin during the secondary wave of 
myogenesis11. By contrast, β-catenin inactivation by Pax7-Cre caused only a modest 




distribution70. Since both Pax7 and En1 are expressed in the central dermoymtome, the 
discrepancies likely reflect different timing of expression and/or efficiency of Cre 
between the two alleles. Analysis of the role of β-catenin via gene inactivation is further 
complicated by an accompanying cell adhesion defect in mutant cells. Inactivation of 
BCL9, which regulates β-catenin’s nuclear activity but not its adhesion function, should 
in principle eliminate this issue. Yet, conditional inactivation of BCL9 by Myf5-Cre, 
causes no developmental defects71. The timing of Myf5-Cre activity and BCL9 protein 
perdurance may obscure a potential role of the canonical pathway in embryonic 
myogenesis. 
The role of Wnt signaling in adult regenerative myogenesis is multifaceted (Fig. 
3). A selective combination of Wnt5a, 5b, 7a, and 7b can convert muscle resident 
CD45+Sca1+ cells (i.e. the side-population cells) to express Pax772, suggesting that 
CD45+Sca1+ cells are a source of de novo Pax7+ stem cells for muscle regeneration. 
Although these Wnt genes were originally reported to be up-regulated during 
regeneration72, subsequent re-evaluation did not substantiate such claim73. Thus, the 
physiological significance of the side-population cells and whether their conversion to 
Pax7+ cells occurs in vivo are not yet known. On the other hand, FGF6 and FGFR4 are 
expressed during the early phase of the regenerative response73,74, and both Fgf6 and 
Fgfr4 mutants display compromised muscle regeneration74,75, supporting the importance 
of FGF signaling pathway for proficient muscle repair. 
For symmetric division of Pax7+ muscle stem cells, Wnt7a has been shown to 
employ the planar cell polarity (PCP) pathway: Wnt7a gene delivery into muscles via 




hypertrophy, and the PCP component Vangl-2 is a likely effector mediating this 
function76. Although β-catenin nuclear localization has been documented in cultured 
proliferating myoblasts, it may act in the transit amplifying progenitors rather than in the 
self-renewing stem cells77. β-catenin nuclear localization is also detected in 
differentiating myogenic cells71. Importantly, BCL9 inactivation or pharmacological 
intervention of β-catenin activity in vivo caused delayed myogenic differentiation but did 
not disturb progenitor proliferation during regeneration, evidence that the canonical 
pathway participates in the differentiation step71,78. Wnt3a has also been shown to employ 
the canonical pathway to accelerate myocyte fusion using the in vitro C2C12 myoblast 
model79. As myocyte fusion immediately follows differentiation, separating Wnt/β-
catenin functions in these two steps in unsynchronized populations of cells may prove to 
be difficult. 
Lastly, Wnt/β-catenin pathway activation also induces muscle fibrosis and thus, is 
implicated in the decline of muscle function in aging. Gene delivery of Wnt3a via 
intramuscular eletroporation leads to fibrotic accumulation76. In vitro, recombinant 
Wnt3a causes direct conversion of myoblasts into fibroblasts78. Importantly, a β-catenin 
transcriptional reporter is activated in aging but not in young muscles after injury, and 
depletion of Wnt proteins via soluble Frz receptors can rejuvenize aged myoblasts to 
prevent fibrogenesis71. While Wnt acts locally to divert aging muscle stem cells to the 
fibrogenic fate, TGFβ1 has been reported to be a candidate systemic factor that may 
attenuate muscle stem cell activation80,81 as serum levels of TGFβ1 increase in aging 




muscle regeneration are primarily based on in vitro culture or in vivo overexpression, 
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